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Abstract: Indoles are omnipresent in natural products, bioactive 
molecules and organic materials. Consequently, their synthesis or 
functionalization are important fields of research in organic chemistry. 
Most works focus on installation or modification of the pyrrole ring. 
To access benzene ring-functionalized indoles with an unsubstituted 
pyrrole ring remains more challenging. Herein we report a platinum-
catalyzed cyclization-alkynylation domino process to obtain 
selectively C5- or C6- functionalized indoles starting from easily 
available pyrroles. Our work combines for the first time a platinum 
catalyst with EthynylBenziodoXole (EBX) hypervalent iodine 
reagents in a domino process for the synthesis of polyfunctionalized 
arene rings and gives access to important building blocks for the 
synthesis of bioactive compounds and organic materials. 
Functionalized indoles occupy a privileged position in organic 
chemistry, as they can be found in biomolecules, drugs, agrochemicals 
and materials.[1] To access these important building blocks, a first 
approach consists in the introduction of functional groups onto simple, 
commercially available indoles. In order to have a more efficient 
alternative to well-established cross-coupling reactions, the transition 
metal-catalyzed direct functionalization of C-H bond on indoles has 
been intensively investigated in the last two decades. Nevertheless, this 
approach is mostly limited to the modification of the more reactive 
pyrrole ring (innate reactivity, Figure 1, A).[2] The functionalization of 
the benzene ring has been only rarely achieved and is limited to C2,C3-
disubstituted indoles.[3] One notable exception is the selective iridium-
catalyzed C7-borylation of indoles reported by Hartwig and co-
workers.[4] We were particularly interested by the introduction of an 
alkyne onto the benzyl ring of indoles, as alkynes are key building 
blocks in medicinal, synthetic and material chemistry.[5] Direct 
alkynylation approaches can be used only to access 2- and 3-
substituted indoles.[6] This is an important limitation, as 5- or 6- 
alkynylated indoles can be found in bioactive compounds such as 5-
LOX (5-lipoxygenase) inhibitor 1,[7a] or NMDA (N-Methyl-D-
Aspartate Receptor) antagonist 2.[7b] Alkynylated carbazoles are 
especially important for organic materials, such as macrocycle 3, an 
organic sensor for the detection of TNT.[7c] If an efficient method for 
the synthesis of benzene-alkynylated indoles can be developed, more 
complex compounds could then be easily obtained by using well-
established C-H functionalization at the C2 or C3 positions or 
transformations of the triple bond. 
As C-H metalation of the arene ring of indoles is extremely difficult in 
presence of the more reactive C2 and C3 C-H bonds, we wondered if 
the desired reactive intermediate could be generated in situ during a 
metal-catalyzed cyclization step (Scheme 1). The use of such “domino” 
or “cascade” processes is one of the most efficient ways to increase 
molecular complexity in organic synthesis,[8] but it had not yet been 
applied to the synthesis of benzene alkynylated indoles. In fact, 
reported cascade approaches by the group of Cacchi and Zhu for the 
synthesis of alkynylated indoles have focused on the construction of 
the pyrrole ring using palladium catalysis (Scheme 1, A).[9] To develop 
a domino process to access indoles functionalized on the benzene ring, 
another type of cyclization would be needed. In this respect, we were 
particularly attracted by the works of Alcaide, Hashmi, and Ma among 
others to form the benzene ring of heterocycles via the cyclization of 
alkynes[10] using well-established π-activation catalysts such as gold 
and platinum.[11] In fact, one single example of gold-catalyzed indole 
ring formation starting from easily available pyrrole ethers has been 
reported.[10b] This precedence gave solid basis for the cyclization step 
of the domino process, but the envisaged alkynylation appeared highly 
challenging, as the generated intermediates are known to broadly favor 
protodemetalation over further C-C bond formation. The formation of a 
new C-C bond on a Csp2 center of an indole arene ring after cyclization 
has to the best of our knowledge never been realized. 
 
 
Figure 1. 5- and 6- alkynylated indoles: outside the scope of C-H 
functionalization! 
To solve the challenge associated with the low reactivity of gold 
intermediates in C-C bond forming reactions, our group has turned to 
the exceptional reactivity of hypervalent iodine alkynylation 
reagents.[6b-d,12] We recently reported the first successful domino 
process in the synthesis of 3-alkynylated furans by the cyclization-
alkynylation of allene ketones.[13] Although this work resulted in the 
synthesis of regioisomers difficult to access via C-H functionalization, 
it was still limited to the more reactive heteroarene class of substrates. 
Herein, we report that the change to a platinum catalyst in combination 
with ethynylbenziodoxole reagent 4a[14] led to a successful cyclization-
alkynylation domino process starting from pyrrole homopropargylic 
ethers to give either C5 or C6-alkynylated indoles in good yields and 
high regioselectivity (Scheme 1, B). In addition to giving access to 
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important building blocks and scaffolds, this new transformation 
represents also a breakthrough in the field of catalysis and hypervalent 
iodine chemistry, as it is the first example of a platinum-catalyzed 
process with EBX reagents. 
 
 
Scheme 1. Domino processes to access alkynylated indoles. 
We started our investigation with pyrrole derivatives 5 and hypervalent 
iodine reagent 4a. Substrate 5 is easily accessible in two steps from 
commercially available compounds and the generation of only one 
molecule of water is required for aromatization. The previous catalytic 
conditions developed in our group for the domino cyclization-
alkynylation of allene ketones[13] were not suitable for the pyrrole 
system. After a broad screening of gold catalysts, the desired product 
could not be obtained. We then turned our attention to platinum 
catalysts (Table 1).[10c,11a] Preliminary results with PtCl2 were 
promising, as 13% of 5-ethynyl indole 8a could be isolated with 
sodium carbonate as base (entry 1). Attempts to modulate the reactivity 
of the catalyst by formation of a more electrophilic platinum salt (entry 
2) or using nitrogen-based ligands (entries 3 and 4) both suppressed the 
formation of 8a. In contrast, changing the base to sodium bicarbonate 
allowed increasing the yield to 40% (entry 5). Investigation of solvents 
showed that CH3CN was best (entries 6-8). Neither the use of other 
hypervalent iodine reagents, such as TIPS-EBX (4b) or 
alkynyliodonium salt 4c (entries 9-10), nor platinum(IV) or (0) 
catalysts (entries 11-12) led to improved results. At this point, we 
decided to investigate the influence of the group eliminated in the 
aromatization step. Changing the leaving group from hydroxy to 
methoxy led to a major increase in yield to 91% (entry 13). A silyl 
ether could also be used, [10b] but led to a lower yield (80%, entry 14). 
A bromide counterion led to a slightly higher yield (entry 15) and an 
iodide completely suppressed the reaction (entry 16). The results 
obtained with PtCl2 and PtBr2 were difficult to reproduce, probably due 
to the poor solubility of reagent 4a in CH3CN. Using a co-solvent led 
to more reproducible results (entries 17-19). THF was the best, giving 
the desired product 8a in 96% yield (entry 18).  
With optimized conditions in hand, we then examined the scope of the 
cyclization-ethynylation domino reaction (Table 2). Indole 8a was 
obtained in 84% isolated yield on a 0.3 mmol scale (entry 1). Only C5-
ethynylation was observed. Modification of the substituent on the 
nitrogen was investigated first. A tolyl and a benzyl group were well 
tolerated (entries 2-3), as well as different substituents on an alkyl 
chain such as methoxy and trifluoromethyl (entries 4-5). Substitution 
of the alkyne was examined next. The desired C5-alkynylated product 
8f was obtained in 70% yield with a methyl group (entry 6). With 
aromatic substituents, formation of the C6-alkynylated product 10 was 
observed for the first time. The C5-alkynylated product 8 was still the 
major product with a phenyl, a tolyl or a para-bromophenyl substituent 
(entries 7-9). The latter case also demonstrated that halogen 
substituents were tolerated under the reaction conditions, allowing 
further functionalization of the products via classical cross-coupling 
chemistry. With a naphthyl group, a 1:1 mixture of regioisomers was 
obtained (entry 10). With a methyl substituent in propargylic position, 
the C5-alkynylated product 8k was obtained in 75% yield (entry 11). In 
contrast, when tertiary ether 6l was used, the C6-alkynylated product 
10e was formed (entry 12). Alkynylated carbazole 8m was obtained in 
76% yield (entry 13). The domino process could also be applied to the 
synthesis of thiophene-fused heterocycle 8n in 78% yield (entry 14). 
 
Table 1. Optimization of the Domino Cyclization-Alkynylation Reaction  
 
entry pyrrole catalyst reagent base solvent yield[a] 
1 5 PtCl2 4a Na2CO3 CH3CN 13% 
2 5 PtCl2/AgOTf 4a Na2CO3 CH3CN <5% 
3 5 PtCl2/bipyridine 4a Na2CO3 CH3CN <5% 
4 5 Pt(NH3)2Cl2 4a Na2CO3 CH3CN <5% 
5 5 PtCl2 4a NaHCO3 CH3CN 40% 
6 5 PtCl2 4a NaHCO3 toluene 30% 
7 5 PtCl2 4a NaHCO3 THF 21% 
8 5 PtCl2 4a NaHCO3 MeOH 14% 
9 5 PtCl2 4b NaHCO3 CH3CN 27% 
10 5 PtCl2 4c NaHCO3 CH3CN <5% 
11 5 PtCl4 4a NaHCO3 CH3CN <5% 
12 5 Pt(PPh3)4 4a NaHCO3 CH3CN <5% 
13 6a PtCl2 4a NaHCO3 CH3CN 91% 
14 7 PtCl2 4a NaHCO3 CH3CN 80% 
15 6a PtBr2 4a NaHCO3 CH3CN 98%[b] 
16 6a PtI2 4a NaHCO3 CH3CN <5% 
17 6a PtBr2 4a NaHCO3 CH3CN/C6H5Cl (v/v = 1/5) 45% 
18 6a PtBr2 4a NaHCO3 CH3CN/THF (v/v = 1/5) 96% 
19 6a PtBr2 4a NaHCO3 CH3CN/THF (v/v = 1/10) 93% 
 
[a]Reaction condition: 5-7 (0.10 mmol), catalyst (10 mol %), 4 (0.20 mmol), 
base (0.20 mmol), 0.1 M, RT, 72 h. Isolated yields after column 
chromatography. [b]Not reproducible. 
Having achieved the synthesis of C5-alkynylated indoles starting from 
C2-substituted pyrroles, we then turned to C3-substituted derivatives to 
achieve C6 functionalization. (Table 3). Pyrrole 9a bearing a terminal 
alkyne gave C6-alkynylated indole 10a exclusively in 77% yield (entry 
1). Substituted alkynes could also be used to access 6,7-disubstituted 
indoles in 47-53% yield (entries 2-4). Starting from tertiary ethers, 4,6-
disubstituted products could be obtained (entries 5 and 6). In this case, 
the same products were obtained as when starting from C2-substituted 
pyrroles. We then wondered if more complex trisubstituted indoles 
could be accessed. In fact, 4,6,7- and 4,5,6-substituted indoles 10g an 
10h could be obtained in 44% and 34% yield respectively (entries 7 
and 8). Although the yields are moderate, the synthesis of these poly-
substituted compounds using another method would have been 
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extremely difficult. Finally, the synthesis of C6-alkynylated carbazoles 
10i-j was also possible (entries 9 and 10). 
 
Table 2. Scope of 5-Alkynylated Indoles.   
entry substrate product yield[a] 
 
  
 
1 R = Me (6a) 8a 84% 
2 R = tolyl (6b) 8b 81% 
3 R = benzyl (6c) 8c 83% 
4 R = 3-methoxy propyl (6d) 8d 80% 
5 R = 1,1,1-trifluorobutyl (6e) 8e 82% 
 
 
 
 
6 R = Me (6f) 8f 70% 
7 R = phenyl (6g) 8g/10c (4/1) 70% (56%)[b] 
8 R = tolyl (6h) 8h/10k (3/1) 69% (52%)[b] 
9 R = p-Br-phenyl (6i) 8i/10l (2.5/1) 62% (44%)[b] 
10 R = naphthyl (6j) 8j/10d (1/1) 31%/31% 
11 
  
75% 
12 
  
54% 
13 
 
 
76% 
14 
 
 
78% 
[a]Reaction conditions: Substrate 6 (0.30 mmol), PtBr2 (10 mol%), EBX reagent 
4a (0.60 mmol), NaHCO3 (0.60 mmol), THF/CH3CN (3 mL, v/v=5/1), 72-120 h, 
isolated yields after column chromatography are given. [b]Yield determined by 
1H NMR. The isolated yield of isomer 8 is given in parenthesis. 
The developed domino process is highly complex. Consequently, any 
proposal about the reaction mechanism is highly speculative at this 
stage of development. Based on the well-established -acidity of 
platinum,[11a] the first step of the catalytic cycle is most probably 
activation of the alkyne to give complex I (Scheme 2). At this point, 
cyclization could occur either on the C2 or C3 position of the pyrrole 
ring to give intermediates II and IV respectively. Attack on the more 
nucleophilic C2 position, leading to II is more probable. From II, two 
different pathways are possible: 1,2 shift of the Pt-bearing vinyl group 
via platinum carbene-cyclopropane intermediate III[11a,15] to give 
carbocation IV, or 1,2-shift of the alkoxy substituent to give 
intermediate VII.[10] C5- or C6- metalated intermediates V and VIII 
will then be generated from IV and VII respectively after 
deprotonation and aromatization via methanol elimination. 
Alkynylated products 8 and 10 can be formed by reaction of EBX 
reagent 4a with the organoplatinum intermediates. As this point, it is 
not clear if the alkynylation step proceeds via an oxidative 
addition/reductive elimination mechanism on platinum[16] or by direct 
nucleophilic attack of the organometallic intermediates onto reagent 
4a.  
Table 3. Scope of 6-Alkynylated Indoles.   
entry substrate product yield[a]  
1 
 
 
77% 
 
 
 
 
2 R = Me (9b) 10b 49% 
3 R = phenyl (9c) 10c 53% 
4 R = naphthyl (9d) 10d 47% 
 
  
 
5 R = Me (9e) 10e 54% 
6 R = phenyl (9f) 10f 65% 
7 
  
44% 
8 
  
34% 
 
 
 
 
9 R = H (9i) 10i 58% 
10 R = OMe (9j) 10j 64% 
[a]Reaction conditions: Substrate 9 (0.30 mmol), PtBr2 (10 mol%), EBX reagent 
4a (0.60 mmol), NaHCO3 (0.60 mmol), THF/CH3CN (3 mL, v/v=5/1), 72-120 h, 
isolated yields after column chromatography are given. 
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If the C3-substituted pyrrole is used as starting material, the 
mechanism is simpler as C2-attack of the indole leads directly to a 6-
membered ring and therefore to exclusive formation of the C6-
alkynylated product 10. The observed regioselectivity for secondary 
ethers is in accordance with a shift of the vinyl group. In contrast, shift 
of the alkoxy group had been observed in the cyclization step when 
using gold catalysts.[10b] This may be due to an easier formation of 
platinum carbene intermediate III when compared to gold catalysts.[17] 
This result further emphasizes an advantage of the platinum catalyst, as 
with gold both C2- and C3-substituted pyrroles would have given C6-
alkynylated products. With pyrroles substituted with tertiary ethers, 
C6-alkynylated products were observed independent of the structure of 
the starting material. In this case, the presence of the methyl group may 
further stabilize transition state VI and favor the shift of the alkoxy 
group. 
 
Scheme 2. Speculative mechanism for the domino cyclization-alkynylation. 
The obtained alkynylated indoles are interesting building blocks, as the 
unsubstituted pyrrole ring can be easily further derivatized using 
established methods and the terminal alkyne obtained after silyl group 
removal can serve as platform for further functionalization. For 
example, deprotection of alkyne 8a followed by gold-catalyzed 
selective C3 alkynylation with TIPS-EBX (4b)[6b] gave monoprotected 
diyne 11, ready for further selective derivatization (Scheme 3, A). 
Starting from naphthyl derivative 10d, deprotection followed by 
platinum-catalyzed cycloisomerization[18] gave access to helicene 12 
(Scheme 3, B). Helicenes are important molecules in asymmetric 
catalysis and material science, but have never been synthesized with a 
terminal pyrrole ring to the best of our knowledge.[19]  
 
Scheme 3. Further transformations of the alkynylated indole products. 
In conclusion, we have reported a new domino cyclization strategy for 
the efficient synthesis of C5- or C6- alkynylated indoles starting from 
easily available C2- or C3-substituted pyrroles. Our strategy is 
complementary to C-H functionalization, as the benzene positions on 
indole are difficult to modify directly, due to the higher reactivity of 
the pyrrole ring. Key for success was the unprecedented combination 
of a platinum catalyst with EthynylBenziodoXole (EBX) reagents. The 
domino process realized in this work represents a new general strategy 
for the synthesis of alkynylated arenes. Further investigations will 
focus on the synthesis of other (hetero)arenes and on the introduction 
of different functional groups in the final bond forming step.[20] 
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1. General method 
 
All reactions were carried out in oven dried glassware under an atmosphere of nitrogen, 
unless stated otherwise. For quantitative flash chromatography technical grade solvents were 
used. For flash chromatography for analysis, HPLC grade solvents from Sigma-Aldrich were 
used. THF, Et2O, CH3CN, toluene, hexane and CH2Cl2 were dried by passage over activated 
alumina under nitrogen atmosphere (H2O content < 10 ppm, Karl-Fischer titration). NEt3 and 
pyridine were distilled under nitrogen from KOH. PtBr2 was purchased from Aldrich, 
crushed into fine powder and kept in desiccator under anhydrous condition (decrease of 
reactivity has been observed for catalyst if prolonged exposition to air (ca 1 month). The 
solvents were degassed by Freeze-Pump-Thaw method when mentioned. All chemicals were 
purchased from Acros, Aldrich, Fluka, VWR, Aplichem or Merck and used as such unless 
stated otherwise. Chromatographic purification was performed as flash chromatography using 
Macherey-Nagel silica 40-63, 60 Å, using the solvents indicated as eluent with 0.1-0.5 bar 
pressure.TLC was performed on Merck silica gel 60 F254 TLC glass plates or aluminium 
plates and visualized with UV light, permanganate stain, CAN stain or Anisaldehyde stain. 
Melting points were measured on a Büchi B-540 melting point apparatus using open glass 
capillaries, the data is uncorrected. 1H-NMR spectra were recorded on a Brucker DPX-400 
400 MHz spectrometer in chloroform-d, DMSO-d6 or CD3OD, all signals are reported in ppm 
with the internal chloroform signal at 7.26 ppm, the internal DMSO signal at 2.50 ppm or the 
internal methanol signal at 3.30 ppm as standard. The data is being reported as (s =  singlet, d 
=  doublet, t =  triplet, q =  quadruplet, qi =  quintet, m =  multiplet or unresolved, br =  
broad signal, app =  apparent, coupling constant(s) in Hz, integration, interpretation).13C-
NMR spectra were recorded with 1H-decoupling on a Brucker DPX-400 100 MHz 
spectrometer in chloroform-d, DMSO-d6 or CD3OD, all signals are reported in ppm with the 
internal chloroform signal at 77.0 ppm, the internal DMSO signal at 39.5 ppm or the internal 
methanol signal at 49.0 ppm as standard. Infrared spectra were recorded on a JASCO FT-IR 
B4100 spectrophotometer with an ATR PRO410-S and a ZnSe prisma and are reported as cm-
1 (w = weak, m =  medium, s =  strong, br =  broad). Gas chromatographic and low 
resolution mass spectrometric measurements were performed on a Perkin-Elmer Clarus 600 
gas chromatographer and mass spectrometer using a Perkin-Elemer Elite fused silica column 
(length: 30 m, diameter: 0.32 mm) and Helium as carrier gas. High resolution mass 
spectrometric measurements were performed by the mass spectrometry service of ISIC at the 
EPFL on a MICROMASS (ESI) Q-TOF Ultima API. HPLC measurement were done on a 
JASCO HPLC system with an AS2055 Autosampler, a PU 2089 Pump, a UV 2075 detector 
and a SEDEX 85 (SEDERE) detector using a CHIRALPAK IC column from DAICEL 
Chemical Industries Ltd. HPLC grade solvents from Sigma-Aldrich were used. 
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2. Preparation of Reagents 
Triisopropylsilyl trimethylsilylacetylene (14) 
 
Following a reported procedure,[1] n-butyllithium (2.5 M in hexanes, 12.0 mL, 29.9 mmol, 
0.98 equiv) was added dropwise to a stirred solution of ethynyltrimethylsilane (13) (3.0 g, 30 
mmol, 1.0 equiv) in THF (48 mL) at -78 °C. The mixture was then warmed to 0 °C and stirred 
for 5 min. The mixture was then cooled back to -78 °C and chlorotriisopropylsilane (6.4 mL, 
30 mmol, 1.0 equiv) was added dropwise. The mixture was then allowed to warm to room 
temperature and stirred overnight. A saturated solution of ammonium chloride (40 mL) was 
added, and the reaction mixture was extracted with diethyl ether (2 x 60 mL). The organic 
layer was washed with water and brine, then dried over MgSO4, filtered and concentrated 
under reduced pressure to obtain a colorless liquid which was further purified by Kugelrohr 
distillation (56-57°C/0.25 mmHg) to yield 14 (7.16 g, 28.0 mmol, 92% yield) as a colorless 
liquid.  
1H NMR (400 MHz, CDCl3) δ 1.08 (m, 21 H, TIPS), 0.18 (s, 9 H, TMS). IR ν 2959 (m), 2944 
(m), 2896 (w), 2867 (m), 1464 (w), 1385 (w), 1250 (m), 996 (w), 842 (s), 764 (s), 675 (m), 
660 (m). Characterization data of 14 corresponded to the literature values.[1] 
1-Chloro-1,3-dihydro-3,3-bis(trifluoromethyl)-1,2-benziodoxole (17) 
 
Following a reported procedure,[2] TMEDA (distilled over KOH) (1.26 mL, 8.20 mmol, 0.2 
equiv) was added to a solution of nBuLi (2.5 M in hexanes, 36.6 mL, 91.6 mmol, 2.2 equiv). 
After 15 min, the cloudy solution was cooled to 0 °C and 15 (7.0 mL, 42 mmol, 1 equiv) in 
THF (6 mL) was added dropwise. The reaction was stirred 30 min at 0 °C and then at RT 
overnight. I2 (11.2 g, 44.0 mmol, 1.06 equiv) was then added portion wise at 0 °C and the 
mixture stirred at 0 °C for 30 min and 4 h at RT. The reaction was quenched with saturated 
NH4Cl. Et2O (100 mL) was added and the layers were separated. The aqueous layer was then 
extracted twice with Et2O (3 x 50 mL). The organic layers were combined, washed twice with 
saturated NaS2O3 (2 x 50 mL), dried over MgSO4, filtered and reduced to afford 15.6 g of 16 
as an brown oil which was used without further purification.  
                                                          
[1] C J. Helal, P A. Magriotis, E J. Corey, J. Am. Chem. Soc. 1996, 118, 10938. 
[2].E. F. Perozzi, R. S. Michalak, G. D. Figuly, W. H. Stevenson, D. B. Dess, M. R. Ross, J. C. Martin, J. Org. 
Chem. 1981, 46, 1049. 
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The crude oil was dissolved in wet CH2Cl2 (40 mL) in the dark under air. 
tBuOCl (5.2 mL, 44 
mmol, 1.05 equiv) was then added dropwise at 0 °C. After 30 min, the resulting suspension 
was filtered to afford 17 (7.30 g, 18.1 mmol, 43%) as a yellow solid. The mother liquors were 
carefully reduced to one third and filtered to afford 17 (3.51 g, 8.71 mmol, 21%) as a yellow 
solid. Combined yield: 64%. Mp 167 – 169°C. 1H NMR (400 MHz, CDCl3) δ 8.09 (d, 1 H, J 
= 8.4 Hz, ArH), 7.85 (m, 1 H, ArH), 7.73 (m, 2 H, ArH). 13C NMR (101 MHz, CDCl3) δ 
133.8, 132.1, 131.6, 129.7, 128.5, 122.8 (q, 289 Hz), 113.4, 84.8. Consistent with reported 
values.[2] 
1-Hydroxy-3,3-bis(trifluoromethyl)-3-(1H)-1,2-benziodoxole (18) 
 
Following a preported procedure,[3] Et3BnNCl (83 mg, 0.36 mmol, 0.05 equiv) was added to a 
stirring solution of 17 (10.7 g, 26.5 mmol, 1 equiv) in CH2Cl2 (150 mL) and KOH (1.48 g, 
26.5 mmol, 1 equiv) in water (28 mL). The reaction was kept under air until TLC indicated 
that all starting material was consumed. The organic layer was separated and dried over 
MgSO4. The resulting solid was purified over a silica plug eluting with EtOAc, then 
recristallized in EtOAC (30 mL) and washed with pentane to afford 18 (7.42 g, 19.2 mmol, 
73%) as a white solid. 1H NMR (400 MHz, DMSO) δ 7.96 (m, 2 H, ArH), 7.73 (m, 2 H, ArH). 
13C NMR (101 MHz, DMSO) δ 133.3, 131.0, 130.8, 128.9, 127.9, 123.4 (q, J = 290 Hz), 
117.2, 83.7 (m). IR 1464 (w), 1435 (w), 1290 (w), 1263 (m), 1185 (s), 1139 (s), 1103 (m), 
1041 (w), 1021 (w), 952 (s), 760 (m), 730 (m), 692 (m).  
1-[(Triisopropylsilyl)ethynyl]-3,3-bis(trifluoromethyl)-3(1H)-1,2-benziodoxole (1a) 
 
TMSOTf (3.80 g, 17.1 mmol, 1.1 equiv) was added to 18 (6.00 g, 15.5 mmol, 1.0 equiv) in 
CH2Cl2 (200 mL) at RT. After 20 min, the solution was concentrated at 0 °C under reduced 
pressure. After evaporation of the solvent, the reaction flask was directly filled with Ar, to 
prevent decomposition of the hygroscopic triflate intermediate. Then the resulting yellow 
solid was dissolved in CH3CN (200 mL). (Trimethylsilyl)(triiso-propylsilyl)acetylene (14) 
(5.14 g, 20.2 mmol, 1.3 equiv) was added and after 20 min several drops of pyridine were 
added. The reaction was then concentrated under vacuum, dissolved in Et2O and filtered over 
                                                          
[3]. A. J. Blake, A. Novak, M. Davies, R. I. Robinson, S. Woodward, Synth. Commun. 2009, 39, 1065 
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a silica plug (eluant Et2O). The resulting solid was recrystallized from pentane to afford 1a 
(5.43 g, 9.87 mmol, 64%) as white crystals.  
Rf (PET/Et2O 95/5): 0.4. Mp 131 – 132°C. 1H NMR (400 MHz, CDCl3) (ca 0.10 mmol/mL) δ 
8.36 (dd, 1 H, J = 7.9, 1.7 Hz, ArH), 7.84 (d, 1 H, J = 6.7 Hz, ArH), 7.68 (m, 2H, ArH), 1.15 
(m, 21 H, TIPS). 13C NMR (101 MHz, CDCl3) δ 132.7, 131.1, 129.9, 129.9 (m), 128.2, 123.6 
(q, 288 Hz), 112.1, 110.8, 81.4 (m), 69.7, 18.5, 11.2. Characterization data of 1a corresponded 
to the literature values.[4] 
1-Hydroxy-1,2-benziodoxol-3-(1H)-one (20) 
 
Following the reported procedure,[ 5 ] NaIO4 (7.24 g, 33.8 mmol, 1.05 equiv) and 2-
iodobenzoic acid (19) (8.00 g, 32.2 mmol, 1.00 equiv) were suspended in 30% (v:v) aq. 
AcOH (48 mL). The mixture was vigorously stirred and refluxed for 4 h. The reaction mixture 
was then diluted with cold water (180 mL) and allowed to cool to rt, protecting it from light. 
After 1 h, the crude product was collected by filtration, washed on the filter with ice water (3 
x 20 mL) and acetone (3 x 20 mL), and air-dried in the dark to give the pure product 20 (8.3 g, 
31 mmol, 98%) as a colorless solid. 
1H NMR (400 MHz, (CD3)2SO) δ 8.02 (dd, 1 H, J = 7.7, 1.4 Hz, ArH), 7.97 (m, 1 H, ArH), 
7.85 (dd, 1 H, J = 8.2, 0.7 Hz, ArH), 7.71 (td, 1 H, J = 7.6, 1.2 Hz, ArH); 13C NMR (100 
MHz, (CD3)2SO) δ 167.7, 134.5, 131.5, 131.1, 130.4, 126.3, 120.4; IR ν 3083 (w), 3060 (w), 
2867 (w), 2402 (w), 1601 (m), 1585 (m), 1564 (m), 1440 (m), 1338 (s), 1302 (m), 1148 (m), 
1018 (w), 834 (m), 798 (w), 740 (s), 694 (s), 674 (m), 649 (m); the reported values correspond 
to the ones in literature.[5] 
1-[(Triiso-propylsilyl)ethynyl]-1,2-benziodoxol-3(1H)-one (TIPS-EBX, 1b) 
 
Following a reported procedure,[6] 2-iodosylbenzoic acid (20) (21.7 g, 82.0 mmol, 1.0 equiv) 
was charged in oven-dried three-neck 1L flask equipped with a magnetic stirrer. After 3 
vacuum/nitrogen cycles, anhydrous acetonitrile (500 mL) was added via canula and cooled to 
0 °C. Trimethylsilyltriflate (16.4 mL, 90.0 mmol, 1.1 equiv) was added dropwise via a 
dropping funnel over 30 min (no temperature increase was observed). After 15 min, 
                                                          
[4] Y. LI, J. Brand, J. Waser, Angew. Chem., Int. Ed. 2013, 52, 6743. 
[5]. L. Kraszkiewicz, L. Skulski,  Arkivoc. 2003, 6, 120. 
[6] J. P. Brand, J. Waser, Angew. Chem., Int. Ed. 2010, 49, 7304. 
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(trimethylsilyl)(triisopropylsilyl)acetylene (14) (23.0 g, 90.0 mmol, 1.1 equiv) was added via 
canula over 15 min (no temperature increase was observed). After 30 min, the suspension 
became an orange solution. After 10 min, pyridine (7.0 mL, 90 mmol, 1.1 equiv) was added 
via syringe. After 15 min, the reaction mixture was transferred in a one-neck 1L flask and 
reduced under vacuum until a solid was obtained. The solid was dissolved in DCM (200 mL) 
and transferred in a 1L separatory funnel. The organic layer was added and washed with 1 M 
HCl (200 mL) and the aqueous layer was extracted with CH2Cl2 (200 mL). The organic layers 
were combined, washed with a saturated solution of NaHCO3 (2 x 200 mL), dried over 
MgSO4, filtered and the solvent was evaporated under reduced pressure. Recrystallization 
from acetonitrile (ca 120 mL) afforded 1b (30.1 g, 70.2 mmol, 86%) as colorless crystals. 
Melting point (Dec.) 170-176°C 
1H NMR (400 MHz, CDCl3) δ 8.44 (m, 1 H, ArH), 8.29 (m, 1 H, ArH), 7.77 (m, 2 H, ArH), 
1.16 (m, 21 H, TIPS). 13C NMR (100 MHz, CDCl3) δ 166.4, 134.6, 132.3, 131.4, 131.4, 
126.1, 115.6, 114.1, 64.6, 18.4, 11.1. IR ν 2943 (m), 2865 (m), 1716 (m), 1618 (m), 1604 (s), 
1584 (m), 1557 (m), 1465 (m), 1439 (w), 1349 (m), 1291 (m), 1270 (w), 1244 (m), 1140 (m), 
1016 (m), 999 (m), 883 (m), 833 (m), 742 (m), 702 (s), 636 (m); Characterization data of 1b 
corresponded to the literature values.[6] 
Phenyl(triisopropylsilyl)iodonium triflate (1c) 
 
Following a slight modification of the reported procedure,[7] phenyliodonium diacetate (21) 
(2.53 g, 7.85 mmol, 1.00 equiv) was diluted with DCM (7 mL) and the mixture was stirred for 
5 minutes. Tf2O (0.60 mL, 3.9 mmol, 0.50 equiv.) was added dropwise at 0 °C and the 
resulting yellow mixture was stirred 30 min. (Trimethylsilyl)(triisopropylsilyl)acetylene (14) 
(2.00 g, 7.86 mmol, 1.00 equiv) was added and the mixture was then stirred 2 h. Water was 
then added (30 mL) followed by extraction of the aqueous layer with DCM (2 x 30 mL). The 
combined organic layers were dried over MgSO4, filtered and the solvent was evaporated 
under reduced pressure. The resulting solid was triturated in hexane (10 mL). Filtration and 
removal of solvent in vacuo afforded phenyl(triisopropylsilyl)iodonium triflate (1c) (2.90 g, 
11.2 mmol, 70% yield) as a colorless solid. 
Melting point: 109 – 114°C. 1H NMR (400 MHz, CDCl3) δ 8.09 (m, 2 H, ArH), 7.65 (m, 1 H, 
ArH), 7.52 (m, 2 H, ArH), 1.15-1.01 (m, 21 H, TIPS); 13C NMR (100 MHz, CDCl3) δ 133.7, 
132.5, 132.4, 119.7, 117.6, 117.6, 44.9, 18.3, 11.1; IR ν 3288 (w), 3088 (m), 2949 (m), 2894 
(m), 2869 (w), 1563 (m), 1467 (w), 1451 (w), 1388 (w), 1281 (s), 1236 (s), 1221 (s), 1174 (s), 
1068 (w), 1028 (s), 988 (m), 916 (m), 884 (m), 736 (s), 679 (m), 639 (s); HRMS (ESI) calcd 
                                                          
[7]. T. Kitamura, M. Kotani, Y. Fujiwara, Synthesis 1998, 10, 1416. 
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for C17H26ISi
+ (M-OTf) 385.0843; found 385.0812; the reported values corresponded to the 
ones in literature.[5] 
 
  
S8 
 
3. Synthesis of starting materials: 
1-(3-Methoxypropyl)-1H-pyrrole-2-carbaldehyde (24) 
 
A solution of 22 (475 mg, 5.00 mmol, 1.0 equiv) in THF (5 mL) was added into a suspension 
of NaH (126 mg, 5.25 mmol, 1.05 equiv) in THF (5 mL). 15 minutes later, 23 (765 mg, 5.00 
mmol, 1.00 equiv) was added into the mixture. The reaction was quenched by sat NH4Cl after 
4 h. The aqueous layer and organic layer were separated and the aqueous layer was extracted 
with ether (3x10 mL). After drying over MgSO4, filtrating and concentrating under vacuum, 
the crude product was purified by column chromatography (Pentane/EtOAc= 10:1) to afford 
24 as brown oil (500 mg, 3.00 mmol, 60 %). 
Rf (Pentane / EtOAc= 10:1): 0.4. 1H NMR (400 MHz, CDCl3) δ 9.37 (s, 1 H, CHO), 6.81 (s, 
1 H, pyrroleH), 6.78 (dd, 1 H, J = 4.0, 1.7 Hz, pyrroleH), 6.06 (dd, 1 H, J = 4.0, 2.5 Hz, 
pyrroleH), 4.24 (t, 2 H, J = 6.8 Hz, NCH2), 3.16 (s, 3 H, OCH3), 3.12 (t, 2 H, J = 5.8 Hz, 
CH2OCH3), 1.85 (m, 2 H, CH2). 
13C NMR (101 MHz, CDCl3) δ 178.5, 131.4, 130.8, 124.3, 
108.9, 68.4, 57.9, 45.5, 30.5. IR 1659 (m), 1482 (w), 1405 (w), 1370 (w), 1322 (w), 1117 (w), 
1071 (w), 913 (w), 732 (s). HRMS (ESI) calcd for C9H13NNaO2
+ [M+Na]+ 190.0838; found 
190.0834. 
1-(4,4,4-Trifluorobutyl)-1H-pyrrole-2-carbaldehyde (26) 
 
A solution of 22 (475 mg, 5.00 mmol, 1.0 equiv) in THF (5 mL) was added into a solution of 
NaH (126 mg, 5.25 mmol, 1.05 equiv) in THF (5 mL). 15 minutes later, 25 (955 mg, 5.00 
mmol, 1.00 equiv) was added into the mixture. The reaction was quenched with sat NH4Cl 
after 4 h. The aqueous and organic layers were separated and the aqueous layer was extracted 
with ether (3x10 mL). After drying over MgSO4, filtrating and concentrating under vacuum, 
the crude product was purified by column chromatography (Pentane/EtOAc= 20:1) to afford 
26 as yellow oil (720 mg, 3.51 mmol, 70 %). 
Rf (Pentane / EtOAc= 20:1): 0.5. 1H NMR (400 MHz, CDCl3) δ 9.44 (d, 1 H, J = 1.0 Hz, 
CHO), 6.87 (m, 2 H, pyrroleH), 6.16 (dd, 1 H, J = 4.0, 2.5 Hz, pyrroleH), 4.30 (t, 2 H, J = 6.8 
Hz NCH2), 1.97 (m, 4 H, CH2CH2). 
13C NMR (101 MHz, CDCl3) δ 179.0, 131.0, 126.7 (q, J 
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= 276.6 Hz), 124.9, 109.6 (two peaks overlap), 47.1, 30.3 (q, J = 29.3 Hz), 23.7 (q, J = 2.9 
Hz). IR 1660 (m), 1482 (w), 1409 (w), 1394 (w), 1370 (w), 1338 (w), 1327 (w), 1316 (w), 
1297 (w), 1280 (w), 1255 (m), 1240 (w), 1221 (w), 1184 (w), 1136 (m), 1079 (w), 1065 (w), 
1033 (m), 1018 (w), 910 (m), 766 (m), 729 (s). HRMS (ESI) calcd for C9F3H11NO
+ [M+H]+ 
206.0787; found 206.0786.  
1-Methyl-1H-pyrrole-3-carbaldehyde (29) 
 
Following a reported procedure[8], dry DMF (1.88 mL, 24.3 mmol, 1.2 equiv) was added into 
a solution of oxalyl dichloride (1.82 mL, 22.3 mmol, 1.1 equiv) in DCM (50 mL) slowly at 0 
˚C. After 15 minutes, the solution turned cloudy. 27 (4.50 g, 20.2 mmol, 1.0 equiv) was added 
into the mixture slowly at 0 ˚C, following by heating the solution at reflux during 1 h. The 
solution was cooled down and filtrated. The filtrating cake was dissolved into 5 % NaOH 
solution (200 mL). The solution was kept stirring during 4 hours, and extracted by ether (3 x 
50 mL). After drying over MgSO4, filtrating and concentrating under vacuum, yellow oil 28 
was obtained as a yellow oil (735 mg, 7.73 mmol, <38%). The crude product was used 
without further purification. 
   A solution of 28 (735 mg, 7.73 mmol, 1.0 equiv) in THF (8 mL) was added into a 
suspension of NaH (291 mg, 8.50 mmol, 1.1 equiv) in THF (8 mL). After 15 minutes, CH3I 
(0.53 mL, 8.5 mmol, 1.1 equiv) was added into the solution.  The reaction was quenched with 
sat NH4Cl after 4 h. The aqueous and organic layers were separated and the aqueous layer was 
extracted with ether (3x10 mL). After drying over MgSO4, filtrating and concentrating under 
vacuum, the crude product was purified by column chromatography (Pentane/EtOAc= 10:1) 
to afford 29 as brown oil (610 mg, 5.59 mmol, 72 %).  
 1H NMR (400 MHz, CDCl3) δ 9.66 (s, 1 H, CHO), 7.20 (t, 1 H, J = 1.8 Hz, pyrroleH), 6.59 
(m, 1 H, pyrroleH), 6.55 (dd, 1 H, J = 2.9, 1.8 Hz, pyrroleH), 3.66 (s, 3 H, CH3). 
13C NMR 
(101 MHz, CDCl3) δ 185.0, 129.9, 126.5, 124.3, 108.1, 36.5.  Characterization data 
corresponded to the literature values[9]. 
 
2-(1-Methoxybut-3-yn-1-yl)-1-methyl-1H-pyrrole  (6a) 
                                                          
[8] B L. Bray, J M. Muchowaski,  J. Org. Chem. 1988,  53, 6115. 
[9] T Purkarthofer, K. Gruber, M. Fechter, H. Griengl,. Tetrahedron. 2005,  61, 7661. 
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A 50 mL two-necked flask was charged with Mg (321 mg, 13.2 mmol, 1.32 equiv), HgCl2 
(2.7 mg, 0.10 mmol, 0.01 equiv) and dry diethyl ether (30 mL), then propargyl bromide was 
added dropwise (2.86 g, 12.0 mmol, 1.20 equiv). When the solution became homogeneous, 30 
(1.09 g, 10.0 mmol, 1.00 equiv) was added dropwise. The reaction was quenched with sat 
NH4Cl solution (30 mL) when TLC (Pentane/EtOAc: 5/1) indicated that the aldehyde was 
completely consumed after 4 hours. The aqueous and organic layers were separated; the 
aqueous layer was extracted with diethyl ether (3×20 mL). The combined organic layers were 
dried over MgSO4 and concentrated under vaccum to obtain 1.34 g crude product as brown oil. 
The crude product was used for the next step directly without further purification. Crude 
propargylic alcohol (1.34 g, 8.98 mmol, 0.89 equiv) in THF (18 mL) was added into a 
suspension of NaH (237 mg, 9.88 mmol, 0.98 equiv) in THF (18 mL). 15 minutes later, MeI 
(1.40 g, 9.88 mmol, 1.10 equiv) was added into the mixture. The reaction was quenched with 
sat NH4Cl after 4 h. The aqueous and organic layers were separated and the aqueous layer was 
extracted with ether (3x10 mL). After drying over MgSO4, filtrating and concentrating under 
vacuum, the crude product was purified by column chromatography (Pentane/EtOAc= 15:1, 
1 % Et3N) to afford 6a as brown oil (1.00 g, 6.13 mmol, 61 % over two steps).  
Rf (Pentane:EtOAc = 25 / 1): 0.6. 1H NMR (400 MHz, CDCl3) δ 6.62 (m, 1 H, pyrroleH), 
6.18 (dd, 1 H, J = 3.6, 1.8 Hz, pyrroleH), 6.10 (dd, 1 H, J = 3.6, 2.7 Hz, pyrroleH), 4.58 (t, 1 
H, J = 6.9 Hz, CHO), 3.68 (s, 3 H, NCH3), 3.27 (s, 3 H, OCH3), 2.79 (ddd, 2 H, J = 16.8, 6.5, 
2.7 Hz, CH2), 2.05 (t, 1 H, J = 2.7 Hz, alkyne CH). 
13C NMR (101 MHz, CDCl3) δ 129.9, 
123.3, 108.5, 106.4, 80.7, 73.9, 69.8, 54.7, 34.0, 24.0. IR 2946 (m), 2866 (m), 2088 (w), 1707 
(s), 1502 (w), 1366 (w), 1274 (w), 1273 (w), 1272 (w), 1253 (w), 1205 (m), 1175 (w), 998 
(w), 886 (m). HRMS (ESI) calcd for C10H13NNaO
+ [M+Na]+ 186.0889; found 186.0895. 
The protocol for the synthesis of 6a represents the typical procedure for the preparation of 6b, 
6c, 6d, 6e, 6f, 6j, 6k, 6l, 6m, 9a, 9e, 9f, 9h, 9i, 9j. 
2-(1-Methoxybut-3-yn-1-yl)-1-(p-tolyl)-1H-pyrrole (6b) 
1.0 g (5.4 mmol) of the corresponding aldehyde was used to obtain the crude 
propargylic alcohol (880 mg, 3.91 mmol, 72%). 440 mg (1.95 mmol) of crude 
propargylic alcohol was used for methylation. 2-(1-Methoxybut-3-yn-1-yl)-1-
(p-tolyl)-1H-pyrrole (6b) was obtained as a colorless oil (398 mg, 1.66 mmol, 
62% over two steps).  
Rf (Pentane / EtOAc = 15 / 1): 0.6. 1H NMR (400 MHz, CDCl3) δ 7.31 (m, 4 H, 
benzene), 6.82 (dd, 1 H, J = 2.7, 1.8 Hz, pyrroleH), 6.43 (dd, 1 H, J = 3.6, 1.8 
Hz, pyrroleH), 6.32 (m, 1 H, pyrroleH), 4.44 (t, 1 H, J = 6.9 Hz, CHOCH3), 
3.20 (s, 3 H, OCH3), 2.71 (ddd, 2 H, J = 15.2, 7.0, 2.7 Hz, CH2), 2.47 (s, 3 H, tolyl CH3), 2.01 
(t, 1 H, J = 2.7 Hz, alkyne CH). 13C NMR (101 MHz, CDCl3) δ 137.4, 137.2, 131.7, 129.5, 
126.5, 123.4, 108.5, 108.0, 80.9, 73.0, 69.8, 55.3, 24.7, 21.0. IR 3303 (w), 2986 (w), 2928 (w), 
2902 (w), 2821 (w), 2246 (w), 2122 (w), 1518 (s), 1468 (m), 1432 (w), 1329 (m), 1241 (w), 
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1183 (w), 1150 (w), 1095 (s), 1046 (w), 1034 (w), 974 (w), 941 (w), 912 (m), 894 (w), 825 (s), 
797 (w), 716 (s), 687 (w), 672 (w), 645 (s), 636 (s), 625 (m), 613 (m). HRMS (ESI) calcd for 
C16H17NaO
+ [M+Na]+ 262.1202; found 262.1198. 
1-Benzyl-2-(1-methoxybut-3-yn-1-yl)-1H-pyrrole (6c) 
690 mg (3.73 mmol) of the corresponding aldehyde was used to obtain the 
crude propargylic alcohol (880 mg, 2.83 mmol, <76%), which was used 
directly in the methylation step. 6c was obtained as a yellow oil (678 mg, 
2.83 mmol, 76% over two steps). 
Rf (Pentane / EtOAc = 25 / 1): 0.5. 1H NMR (400 MHz, CDCl3) δ 7.32 (m, 
3 H, benzene), 7.09 (d, 2 H, J = 7.0 Hz, benzene), 6.72 (dd, 1 H, J = 2.6, 
1.7 Hz, pyrroleH), 6.29 (dd, 1 H, J = 3.6, 1.7 Hz, pyrroleH), 6.21 (m, 1 H, 
pyrroleH), 5.23 (s, 2 H, NCH2), 4.51 (t, 1 H, J = 6.8 Hz, CHOCH3), 3.17 (s, 3 H, OCH3), 2.69 
(ddd, 2 H, J = 16.5, 7.2, 2.7 Hz, CH2), 2.02 (t, 1 H, J = 2.7 Hz, alkyne CH). 
13C NMR (101 
MHz, CDCl3) δ 138.0, 130.1, 128.3, 127.0, 126.2, 122.8, 108.5, 107.0, 80.6, 73.5, 69.9, 54.5, 
50.2, 24.1. IR 2247 (w), 2123 (w), 1735 (w), 1497 (w), 1482 (w), 1455 (w), 1357 (w), 1299 
(w), 1096 (m), 1078 (m), 909 (s), 728 (s). HRMS (ESI) calcd for C16H17NNaO
+ [M+Na]+ 
262.1202; found 262.1207. 
2-(1-Methoxybut-3-yn-1-yl)-1-(3-methoxypropyl)-1H-pyrrole (6d) 
573 mg of 24 (3.73 mmol) was used to obtain the crude propargylic 
alcohol (490 mg, 2.21 mmol, <74%), which was used directly in the 
methylation step. 6d was obtained as yellow oil (248 mg, 1.12 mmol, 40% 
over two steps). 
Rf (Pentane / EtOAc = 25 / 1): 0.6. 1H NMR (400 MHz, CDCl3) δ 6.66 
(dd, 1 H, J = 2.8, 1.8 Hz, pyrroleH), 6.15 (m, 1 H, pyrroleH), 6.09 (dd, 1 
H, J = 3.5, 2.8 Hz, pyrroleH), 4.58 (t, 1 H, J = 6.9 Hz, CHOCH3), 4.03 
(m, 2 H, NCH2), 3.33 (s, 3H, CHOCH3), 3.32 (m, 2 H, CH2OCH3), 3.23 (s, 3H, CH2OCH3),  
2.77 (ddd, 2 H, J = 16.2, 6.7, 2.7 Hz, CH2), 1.99 (m, 3 H, alkyne CH + NCH2CH2). 
13C NMR 
(101 MHz, CDCl3) δ 129.8, 122.0, 107.8, 106.8, 80.8, 73.1, 69.9, 68.9, 58.3, 54.4, 43.3, 31.3, 
23.9. IR 1664 (w), 1483 (w), 1458 (w), 1348 (w), 1297 (w), 1190 (w), 1116 (s), 1075 (s), 
1029 (w), 914 (w), 833 (w), 717 (s). HRMS (ESI) calcd for C13H19NaO2
+ [M+Na]+ 244.1308; 
found 244.1306.  
2-(1-Methoxybut-3-yn-1-yl)-1-(4,4,4-trifluorobutyl)-1H-pyrrole (6e) 
720 mg of 27 (3.51 mmol) was used to obtain the crude propargylic 
alcohol (850 mg, 3.47 mmol, <99%), which was used directly in the 
methylation step. 6e was obtained as yellow oil (548 mg, 2.11 mmol, 
60 % over two steps). 
Rf (Pentane / EtOAc = 25 / 1): 0.4. 1H NMR (400 MHz, CDCl3) δ 6.67 
(dd, 1 H, J = 2.7, 1.8 Hz, pyrroleH), 6.21 (dd, 1 H, J = 3.6, 1.8 Hz, 
pyrroleH), 6.15 (m, 1 H, pyrroleH), 4.58 (t, 1 H, J = 7.0 Hz, CHOCH3), 
4.03 (m, 2 H, NCH2), 3.25 (s, 3 OCH3), 2.81 (ddd, 2 H, J = 16.8 Hz , 
6.9 Hz, 2.7 Hz, CH2), 2.08 (m, 4 H, CH2CH2CF3), 2.03 (t, 1 H, J = 2.7 Hz, alkyne CH). 
13C 
NMR (101 MHz, CDCl3) δ 129.8, 126.8 (q, J = 276.6 Hz), 121.8, 108.7, 107.4, 80.5, 73.3, 
70.1, 54.2, 45.3, 30.9 (q, J = 29.3 Hz), 23.9 (q, J = 2.9 Hz). 23.6. IR 3310 (w), 2945 (w), 2338 
(w), 1485 (w), 1455 (w), 1393 (w), 1374 (w), 1318 (w), 1295 (m), 1255 (s), 1212 (w), 1135 
(s), 1119 (m), 1095 (m), 1080 (m), 1027 (m), 1009 (w), 913 (w), 833 (w), 795 (w), 720 (s). 
HRMS (ESI) calcd for C13H16F3NNaO
+ [M+Na]+ 282.1076; found 282.1078. 
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2-(1-Methoxypent-3-yn-1-yl)-1-methyl-1H-pyrrole (6f) 
1.0 g of 30 (5.4 mmol) was used to obtain crude propargylic alcohol (880 mg, 
3.91 mmol, <72%). 448 mg of crude propargylic alcohol (3.00 mmol), NaH 
(144 mg, 6.00 mmol, 2 equiv) and CH3I (1.06 g, 7.50 mmol, 2.5 equiv) were 
used for the methylation. 6f was obtained as yellow oil (384 mg, 1.83 mmol, 48% 
over two steps).  
Rf (Pentane / EtOAc = 15 / 1): 0.5. 1H NMR (400 MHz, CDCl3) δ 6.59 (m, 1 H, 
pyrroleH), 6.15 (dd, 1 H, J = 3.6, 1.8 Hz, pyrroleH), 6.08 (dd, 1 H, J = 3.6, 2.7 
Hz, pyrroleH), 4.50 (m, 1 H, CHOCH3), 3.66 (s, 3 H, NCH3), 3.25 (s, 3 H, OCH3), 2.72 (m, 2 
H, CH2), 1.79 (t, 3 H, J = 2.6 Hz, CH3). 
13C NMR (101 MHz, CDCl3) δ 130.4, 123.1, 108.2, 
106.4, 76.9, 75.4, 74.4, 54.6, 33.9, 24.3, 3.3. IR 2978 (w), 2937 (w), 2921 (w), 2869 (w), 
2821 (w), 1706 (w), 1494 (w), 1466 (w), 1465 (w), 1438 (w), 1421 (w), 1345 (w), 1302 (m), 
1095 (s), 1059 (w), 1003 (w), 955 (w). HRMS (ESI) calcd for C11H15NNaO
+ [M+Na]+ 
200.1046; found 200.1047.  
2-(1-Methoxy-4-phenylbut-3-yn-1-yl)-1-methyl-1H-pyrrole (6g) 
 
Iodobenzene (31) (179 mg, 0.880 mmol, 1.1 equiv) was added into a solution of 6a (130 mg, 
0.800 mmol, 1.0 equiv), Pd(PPh3)Cl2 (6.3 mg, 0.033 mmol, 0.03 equiv) and CuI (39 mg, 
0.055 mmol, 0.05 equiv) in degased THF (2 mL) and Et3N (2 mL). The mixture was kept 
overnight at 60 ˚C. The reaction was filtered through a plug of celite and the crude was 
purified by column chromatography (Pentane/EtOAc= 50:1, 1 % Et3N) to afford 6g as brown 
oil (236 mg, 0.986 mmol, 90 %).  
Rf (Pentane / EtOAc = 50 / 1): 0.3. 1H NMR (400 MHz, CDCl3) δ 7.41 (m, 2 H, benzeneH), 
7.29 (m, 3 H, benzeneH), 6.63 (dd, 1 H, J = 2.5, 2.0 Hz, pyrroleH), 6.24 (m, 1 H, pyrroleH), 
6.12 (dd, 1 H, J = 3.5, 2.7 Hz, pyrroleH), 4.64 (t, 1 H, J = 6.9 Hz, CHOCH3), 3.70 (s, 3 H, 
NCH3), 3.33 (s, 3 H, OCH3), 3.01 (dd, 2 H, J = 16.8, 6.6 Hz, CH2). 
13C NMR (101 MHz, 
CDCl3) δ 131.6, 130.5, 128.1, 127.7, 123.6, 123.4, 108.6, 106.6, 86.5, 82.1, 74.6, 55.3, 34.2, 
25.5. IR 2361 (w), 1491 (m), 1465 (w), 1443 (w), 1417 (w), 1344 (w), 1300 (w), 1091 (s), 
1061 (w), 950 (w), 910 (s), 758 (m), 729 (s). HRMS (ESI) calcd for C16H18NO
+ [M+H]+ 
240.1383; found 240.1388. 
The protocol for 6g represents the typical procedure for the synthesis of 6h, 6i, 9c and 9d. 
2-(1-Methoxy-4-(p-tolyl)but-3-yn-1-yl)-1-methyl-1H-pyrrole (6h) 
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Following the conditions described for 6g, 6a (194 mg, 1.19 mmol) was used. The crude 
product was purified by flash column chromatography (Pentane/EtOAc= 50:1, 1 % Et3N) to 
afford 6h as yellow oil (267 mg, 1.05 mmol, 88%) 
Rf (Pentane / EtOAc = 50 / 1): 0.5. 1H NMR (400 MHz, CDCl3) δ 7.32 (d, 2 H, J = 8.1 Hz, 
benzeneH), 7.12 (m, 2 H, benzeneH), 6.64 (t, 1 H, J = 2.0 Hz, pyrroleH), 6.25 (dd, 1 H, J = 
3.6, 1.8 Hz, pyrroleH), 6.14 (m, 1 H, pyrroleH), 4.65 (t, 1 H, J = 6.9 Hz, CHOCH3), 3.71 (s, 3 
H, NCH3), 3.34 (s, 3 H, OCH3), 3.02 (dd, 2 H, J = 16.8, 6.6 Hz, CH2), 2.37 (s, 3 H, CH3). 
13C 
NMR (101 MHz, CDCl3) δ 137.6, 131.4, 130.6, 128.8, 123.3, 120.5, 108.5, 106.6, 85.6, 82.1, 
74.6, 55.2, 34.1, 25.5, 21.3. IR 2981 (w), 2927 (m), 2362 (w), 1712 (w), 1508 (m), 1496 (w), 
1445 (w), 1444 (w), 1345 (w), 1301 (w), 1267 (w), 1186 (w), 1093 (s), 950 (w), 820 (s), 786 
(w), 717 (s). HRMS (ESI) calcd for C17H20NO
+ [M+H]+ 254.1539; found 254.1542. 
2-(4-(4-Bromophenyl)-1-methoxybut-3-yn-1-yl)-1-methyl-1H-pyrrole (6i) 
 
 
 
Following the conditions described for 6g, 6a (163 mg, 1.00 mmol) was used. The crude 
product was purified by flash column chromatography (Pentane/EtOAc= 20:1, 1 % Et3N) to 
afford 6i as yellow oil (260 mg, 0.817 mmol, 82 %) 
Rf (Pentane / EtOAc = 20 / 1): 0.2  
1H NMR (400 MHz, CDCl3) δ 7.31 (d, 2 H, J = 8.5 Hz, benzeneH), 7.15 (d, 2 H, J = 8.5 Hz 
benzeneH), 6.52 (t, 1 H, J = 2.1 Hz, pyrroleH), 6.12 (dd, 1 H, J = 3.5, 1.7 Hz, pyrroleH), 6.01 
(m, 1 H, pyrroleH), 4.53 (t, 1 H, J = 6.9 Hz, CHOCH3), 3.59 (s, 3 H, NCH3), 3.21 (s, 3 H, 
OCH3), 2.89 (ddd, 2 H, J = 16.9, 7.2, 2.6 Hz, CH2). 
13C NMR (101 MHz, CDCl3) δ 133.0, 
131.3, 130.3, 123.4, 122.5, 121.7, 108.6, 106.6, 87.8, 81.0, 74.3, 55.2, 34.2, 25.4. IR 2981 (m), 
2930 (m), 2907 (m), 2819 (w), 1488 (m), 1344 (w), 1300 (w), 1076 (s), 1008 (w), 990 (w), 
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826 (s), 787 (w), 716 (s). HRMS (ESI) calcd for C16H17BrNO
+ [M+H]+ 318.0488; found 
318.0484. 
 
2-(1-Methoxy-4-(naphthalen-1-yl)but-3-yn-1-yl)-1-methyl-1H-pyrrole (6j) 
 
Following the conditions described for 6g, 6a (163 mg, 1.00 mmol) was used. The crude 
product was purified by flash column chromatography (Pentane/EtOAc= 50:1, 1 % Et3N) to 
afford 6j as yellow oil (269 mg, 0.930 mmol, 93%) 
Rf (Pentane / EtOAc = 50 / 1): 0.3. 1H NMR (400 MHz, CDCl3) δ 8.24 (d, 1 H, J = 8.0 Hz, 
benzeneH), 7.84 (m, 2 H, benzeneH), 7.67 (d, 1 H, J = 6.8 Hz, benzeneH), 7.56 (m, 2 H, 
benzeneH), 7.43 (m, 1 H, benzeneH), 6.69 (m, 1 H, pyrroleH), 6.37 (dd, 1 H, J = 3.5, 1.7 Hz, 
pyrroleH), 6.22 (m, 1 H, pyrroleH), 4.76 (t, 1 H, J = 7.1 Hz, CHOCH3), 3.74 (m, 3 H, NCH3), 
3.39 (s, 3 H, OCH3), 3.21 (dd, 2 H, J = 16.8, 6.6 Hz, CH2). 
13C NMR (101 MHz, CDCl3) δ 
133.4, 133.0, 130.4, 129.9, 128.0, 128.0, 126.5, 126.3, 126.1, 125.0, 123.4, 121.2, 108.9, 
106.7, 91.4, 80.2, 74.6, 55.3, 34.2, 25.8. IR 3053 (w), 2979 (w), 2931 (m), 1738 (w), 1664 (w), 
1582 (w), 1497 (m), 1466 (w), 1427 (w), 1405 (w), 1343 (w), 1300 (w), 1198 (w), 1187 (w), 
1168 (w), 1162 (w), 1092 (s), 969 (w), 802 (s), 778 (s), 718 (s). HRMS (ESI) calcd for 
C20H20NO
+ [M+H]+ 290.1539; found 290.1541. 
2-(1-Methoxy-2-methylbut-3-yn-1-yl)-1-methyl-1H-pyrrole (6k) 
218 mg of 30 (2.00 mmol, 1.0 equiv) and 3-bromobut-1-yne (319 mg, 2.40 
mmol) were used to obtain the crude propargylic alcohol (300 mg, 1.84 mmol, 
<92%), which was used directly in the methylation step. 6k was obtained as 
transparent oil (260 mg, 1.47 mmol, 74% over two steps as a mixture of 
diastereoisomers, the major one was characterized).  
Rf (Pentane / EtOAc = 15 / 1): 0.5. 1H NMR (400 MHz, CDCl3) δ 6.58 (m, 1 H, pyrroleH), 
6.11 (m, 1 H, pyrroleH), 6.07 (m, 1 H, pyrroleH), 4.22 (d, 1 H, J = 8.9 Hz, CHOCH3), 3.66 (s, 
3 H, NCH3), 3.24 (s, 3 H, OCH3), 2.93 (m, 1 H, CHCH3), 2.15 (d, 1 H, J = 2.4 Hz, alkyne 
CH), 1.05 (d, 3 H, J = 7.1 Hz, CH3). 
13C NMR (101 MHz, CDCl3) δ 128.8, 123.6, 110.3, 
106.7, 86.7, 80.2, 69.2, 56.1, 34.5, 31.4, 17.7. IR 3291 (w), 3282 (w), 2979 (w), 2935 (w), 
2901 (w), 2821 (w), 1493 (w), 1451 (w), 1417 (w), 1376 (w), 1298 (m), 1204 (w), 1132 (w), 
1092 (s), 960 (w), 924 (w), 805 (w), 783 (w), 715 (s), 688 (m), 678 (m), 651 (s), 632 (m), 615 
(m).  HRMS (ESI) calcd for C11H16NO
+ [M+H]+ 178.1226; found 178.1235. 
2-(2-Methoxypent-4-yn-2-yl)-1-methyl-1H-pyrrole (6l) 
246 mg of the corresponding ketone (2.00 mmol) was used to obtain the crude 
propargylic alcohol (300 mg, 1.84 mmol, <92%), which was used directly in 
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the methylation step. 6l was obtained as yellow oil (230 mg, 1.30 mmol, 65 % over two steps).  
Rf (Pentane / EtOAc = 15 / 1): 0.6. 1H NMR (400 MHz, CDCl3) δ 6.59 (m, 1 H, pyrroleH), 
6.07 (dd, 1 H, J = 3.7, 1.9 Hz, pyrroleH), 6.03 (dd, 1 H, J = 3.7, 2.7 Hz, pyrroleH), 3.76 (s, 3 
H, NCH3), 3.07 (s, 3 H, OCH3), 2.82 (dd, 2 H, J = 16.0 Hz, 2.7 Hz, CH2), 2.05 (t, 1 H, J = 2.7 
Hz, alkyne CH), 1.70 (s, 3 H, CH3). 
13C NMR (101 MHz, CDCl3) δ 132.3, 124.6, 109.5, 106.0, 
80.2, 75.6, 70.7, 50.4, 35.3, 29.9, 23.8. IR 3304 (w), 3292 (w), 2983 (m), 2942 (m), 2867 (w), 
2824 (w), 2146 (w), 1653 (w), 1532 (w), 1512 (w), 1486 (m), 1430 (w), 1411 (w), 1372 (w), 
1353 (w), 1311 (m), 1294 (m), 1262 (w), 1239 (w), 1203 (w), 1154 (w), 1099 (s), 1062 (s), 
896 (w), 885 (w), 859 (w), 844 (m), 822 (w). HRMS (ESI) calcd for C11H15NNaO
+ [M+Na]+ 
200.1046; found 200.1046. 
2-(1-Methoxybut-3-yn-1-yl)-1-methyl-1H-indole (6m) 
478 mg of the corresponding aldehyde (3.00 mmol) was used to obtain 
the crude propargylic alcohol (500 mg, 2.51 mmol, <84%), which was 
used directly in the methylation step. 6m was obtained as a yellow oil 
(450 mg, 2.11 mmol, 70 % over two steps).  
Rf (Pentane / EtOAc = 25 / 1): 0.5. 1H NMR (400 MHz, CDCl3) δ 7.84 
(d, 1 H, J = 7.8 Hz, benzeneH), 7.50-7.43 (m, 2 H, benzeneH), 7.35 (m, 1 
H, benzeneH), 6.73 (s, 1 H, pyrroleH), 4.89 (t, 1 H, J = 6.9 Hz, 
CHOCH3), 3.91 (s, 3 H, NCH3), 3.47 (s, 3 H, OCH3), 3.04 (ddd, 2 H, J = 16.4, 7.3, 2.7 Hz, 
CH2), 2.29 (t, 1 H, J = 2.7 Hz, alkyne CH). 
13C NMR (101 MHz, CDCl3) δ 137.9, 137.0, 
126.9, 121.5, 120.4, 119.3, 108.8, 101.6, 80.2, 74.7, 70.3, 55.2, 29.9, 24.4.  IR 3667 (w), 3479 
(w), 2992 (s), 2961 (m), 2906 (m), 1402 (w), 1248 (w), 1236 (w), 1072 (s), 1034 (m), 901 (w), 
866 (w). HRMS (ESI) calcd for C14H15NO [M]
+ 214.1226; found 214.1228. 
5-(1-Methoxybut-3-yn-1-yl)-4-methyl-4H-thieno[3,2-b]pyrrole (6n) 
250 mg of the corresponding aldehyde (1.51 mmol) was used to obtain the 
crude propargylic alcohol (250 mg, 1.22 mmol, <81%). 123 mg of crude 
propargylic alcohol (0.599 mmol) was used for methylation. 6n was 
obtained as a yellow oil (93 mg, 0.42 mmol, 57% over two steps). 
Rf (Pentane / EtOAc = 15 / 1): 0.5. 1H NMR (400 MHz, CDCl3) δ 7.10 (d, 
1 H, J = 5.3 Hz, thiopheneH), 6.94 (d, 1 H, J = 5.3, thiopheneH), 6.44 (s, 1 
H, pyrroleH), 4.64 (t, 1 H, J = 7.1 Hz, CHOCH3), 3.81 (s, 3 H, NCH3), 3.32 
(s, 3 H, OCH3), 2.84 (ddd, 2 H, J = 15.2, 7.3, 2.7 Hz, CH2), 2.06 (t, 1 H, J = 2.7 Hz, alkyne 
CH). 13C NMR (101 MHz, CDCl3) δ 142.0, 135.3, 123.3, 121.4, 109.8, 100.9, 80.5, 75.1, 70.2, 
55.4, 32.6, 24.7. IR 3285 (w), 2934 (w), 2821 (w), 1530 (w), 1399 (w), 1354 (w), 1319 (w), 
1187 (w), 1135 (w), 1095 (m), 1085 (m), 1006 (w), 840 (w), 769 (w), 714 (s), 687 (m), 677 
(s), 663 (s), 655 (s), 613 (w). HRMS (ESI) calcd for C12H14NOS
+ [M+H]+ 220.0791; found 
220.0786.  
3-(1-Methoxybut-3-yn-1-yl)-1-methyl-1H-pyrrole (9a) 
610 mg of 29 (5.59 mmol) was used to obtain the crude propargylic alcohol 
(600 mg, 4.02 mmol, <72%), which was used directly in the methylation step. 
9a was obtained as yellow oil (480 mg, 2.94 mmol, 53% over two steps).  
Rf (Pentane / EtOAc = 15 / 1): 0.6. 1H NMR (400 MHz, CDCl3) δ 6.60 (s, 1 H, 
pyrroleH ), 6.54 (t, 1 H, J = 2.5 Hz, pyrroleH), 6.11 (m, 1 H, pyrroleH), 4.28 (t, 
1 H, J = 6.5 Hz, CHOCH3), 3.59 (s, 3 H, NCH3), 3.27 (s, 3 H, OCH3), 2.64 (ddd, 
2 H, J = 16.4, 6.2, 2.7 Hz, CH2), 1.97 (t, 1 H, J = 2.6 Hz, alkyne CH). 
13C NMR (101 MHz, 
CDCl3) δ 122.8, 121.4, 119.6, 106.3, 81.4, 75.5, 69.0, 55.5, 35.5, 26.6. IR 3303 (w), 2939 (m), 
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2868 (w), 2820 (w), 1558 (w), 1509 (w), 1466 (w), 1424 (w), 1319 (w), 1270 (w), 1165 (w), 
1164 (w), 1099 (s), 1005 (w), 822 (w), 787 (w), 740 (m), 706 (w).  HRMS (ESI) calcd for 
C10H13NNaO
+ [M+Na]+ 186.0889; found 186.0895. 
3-(1-Methoxypent-3-yn-1-yl)-1-methyl-1H-pyrrole (9b) 
 
BuLi (0.386 mL, 0.965 mmol, 1.05 equiv) was added to a solution of 9a (150 mg, 0.919 
mmol, 1.0 equiv) in dry THF (3 mL) at – 78 oC. The solution was kept during 30 minutes at – 
78 oC and 15 minutes at room temperature. Then the solution was re-cooled down to – 78 oC, 
MeI (272 mg, 1.92 mmol, 1.0 equiv) was added dropwise. The reaction was quenched with a 
sat NH4Cl solution (30 mL) 2 hours later. The aqueous and organic layers were separated and 
the aqueous layer was extracted with ether (3x10 mL). After drying over MgSO4 and 
concentrating under vacuum, the crude product was purified by column chromatography 
(Pentane/EtOAc= 25:1, 1 % Et3N) to afford 9b as brown oil (89 mg, 0.50 mmol, 55 %) 
Rf (Pentane/EtOAc= 25:1): 0.3. 1H NMR (400 MHz, CDCl3) δ 6.58 (t, 1 H, J = 1.9 Hz, 
pyrroleH), 6.54 (t, 1 H, J = 2.5 Hz, pyrroleH), 6.11 (m, 1 H, pyrroleH), 4.22 (t, 1 H, J = 6.3 
Hz, CHOCH3), 3.62 (s, 3 H, NCH3), 3.28 (s, 3 H, OCH3), 2.67-2.50 (m, 2 H, CH2), 1.78 (t, 3 
H, J = 2.5 Hz, alkyne CH3). 
13C NMR (101 MHz, CDCl3) δ 123.6, 121.6, 119.8, 106.6, 76.4, 
76.4, 76.3, 56.0, 35.9, 27.3, 3.5. IR 3667 (w), 3522 (w), 3512 (w), 3489 (w), 3479 (w), 2992 
(s), 2961 (m), 2960 (m), 2906 (m), 1402 (w), 1248 (w), 1072 (s), 1034 (m), 900 (w), 865 (w), 
746 (w). HRMS (ESI) calcd for C11H15NNaO
+ [M+Na]+ 200.1046; found 200.1047. 
3-(1-Methoxy-4-phenylbut-3-yn-1-yl)-1-methyl-1H-pyrrole (9c) 
 
Following the conditions described for 6g, 9a (289 mg, 1.77 mmol) was used. The crude 
product was purified by flash column chromatography (Pentane/EtOAc= 50:1, 1 % Et3N) to 
afford 9c as yellow oil (334 mg, 1.40 mmol, 79%). 
Rf (Pentane / EtOAc = 50 / 1): 0.4. 1H NMR (400 MHz, CDCl3) δ 7.50-7.47 (m, 2 H, 
benzeneH), 7.34-7.31 (m, 3 H, benzeneH), 6.69 (t, 1 H, J = 1.8 Hz, pyrroleH), 6.62 (t, 1 H, J 
= 2.4 Hz, pyrroleH), 6.26 (m, 1 H, pyrroleH), 4.45 (t, 1 H, J = 6.4 Hz, CHOCH3), 3.63 (s, 3 H, 
NCH3), 3.41 (s, 3 H, OCH3), 2.96 (dd, 2 H, J = 16.2, 6.7 Hz, CH2). 
13C NMR (101 MHz, 
CDCl3) δ 131.3, 127.8, 127.2, 123.8, 123.4, 121.6, 119.7, 106.6, 87.5, 81.4, 76.2, 56.0, 35.7, 
28.1. IR 2936 (w), 2935 (w), 2243 (w), 1508 (w), 1495 (w), 1163 (w), 1096 (m), 909 (s), 785 
(w), 729 (s). HRMS (ESI) calcd for C16H17NO
+ [M+] 262.1202; found 262.1207. 
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3-(1-Methoxy-4-(naphthalen-1-yl)but-3-yn-1-yl)-1-methyl-1H-pyrrole (9d) 
 
Following the conditions described for 6g, 9a (163 mg, 1.00 mmol) was used. The crude 
product was purified by flash column chromatography (Pentane/EtOAc= 50:1, 1 % Et3N) to 
afford 9d as yellow oil (210 mg, 0.730 mmol, 73 %). 
Rf (Pentane / EtOAc = 50 / 1): 0.4. 1H NMR (400 MHz, CDCl3) δ 8.11-8.08 (m, 1 H, 
benzeneH), 7.71-7.69 (m, 1 H, benzeneH), 7.65 (d, 1 H, J = 8.3 Hz, benzeneH), 7.51 (d, 1 H, J 
= 7.1 Hz, benzeneH), 7.41-7.37 (m, 2 H, benzeneH), 7.27 (m, 1 H, benzeneH), 6.58 (s, 1 H, 
pyrroleH), 6.50 (t, 1 H, J = 2.3 Hz, pyrroleH), 6.14 (m, 1 H, pyrroleH), 4.36 (t, 1 H, J = 6.6 
Hz, CHOCH3), 3.52 (s, 3 H, NCH3), 3.28 (s, 3 H, OCH3), 2.94 (dd, 2 H, J = 16.6, 6.8 Hz, 
CH2). 
13C NMR (101 MHz, CDCl3) δ 133.6, 133.1, 129.8, 128.0, 127.9, 126.5, 126.2, 126.1, 
125.1, 123.6, 121.9, 121.6, 120.2, 106.9, 92.6, 79.7, 76.5, 56.3, 36.1, 28.4. IR 3052 (w), 2975 
(w), 1735 (w), 1583 (w), 1555 (w), 1507 (w), 1218 (w), 1163 (m), 1094 (s), 1006 (w), 962 
(w), 914 (w), 799 (s), 776 (s), 703 (w). HRMS (ESI) calcd for C20H20NO
+ [M+] 312.1359; 
found 312.1356.  
3-(2-Methoxypent-4-yn-2-yl)-1-methyl-1H-pyrrole (9e) 
616 mg of the corresponding ketone (5.00 mmol) was used to obtain the crude 
propargylic alcohol (555 mg, 3.40 mmol, <68%). 326 mg of crude propargylic 
alcohol (2.00 mmol) was used for methylation. 9e was obtained as a transparent 
oil (297 mg, 1.68 mmol, 57% over two steps).  
Rf (Pentane / EtOAc = 15 / 1): 0.6. 1H NMR (400 MHz, CDCl3) δ 6.55 (d, 2 H, 
J = 2.3 Hz, pyrroleH), 6.10 (t, 1 H, J = 2.3 Hz, pyrroleH), 3.62 (s, 3 H, NCH3), 
3.09 (s, 3 H, OCH3), 2.68 (dd, 2 H, J = 16.0 Hz, 2.7 Hz, CH2), 2.00 (t, 1 H, J = 2.7 Hz, alkyne 
CH), 1.60 (s, 3 H, CH3). 
13C NMR (101 MHz, CDCl3) δ 126.3, 121.6, 119.5, 106.8, 81.3, 74.6, 
70.0, 50.1, 35.9, 31.8, 23.5. IR 3686 (w), 3674 (w), 3296 (w), 3285 (w), 2987 (s), 2941 (m), 
2940 (m), 2910 (m), 2902 (s), 2822 (w), 1556 (w), 1509 (w), 1473 (w), 1456 (w), 1420 (w), 
1407 (w), 1394 (w), 1378 (w), 1258 (w), 1251 (w), 1243 (w), 1233 (w), 1210 (w), 1191 (w), 
1098 (s), 1092 (s), 1067 (s), 1059 (s), 1017 (w), 787 (w), 744 (m), 699 (w), 682 (w), 660 (s), 
652 (m), 644 (s), 633 (m), 622 (w), 606 (w). HRMS (ESI) calcd for C11H15NNaO
+ [M+Na]+ 
200.1046; found 200.1039. 
3-(1-Methoxy-1-phenylbut-3-yn-1-yl)-1-methyl-1H-pyrrole (9f) 
460 mg of the corresponding ketone (2.48 mmol) was used to obtain the crude 
propargylic alcohol (500 mg, 2.20 mmol, <89%). 250 mg of crude propargylic 
alcohol (1.11 mmol) was used for methylation. 9f was obtained as yellow oil 
(106 mg, 0.443 mmol, 36 % over two steps).  
Rf (Pentane / EtOAc = 25 / 1): 0.8. 1H NMR (400 MHz, CDCl3) δ 7.51 (m, 2 
H, benzeneH), 7.33 (m, 2 H, benzeneH), 7.26 (m, 1 H, benzeneH), 6.56 (m, 2 
H, pyrroleH), 6.04 (dd, 1 H, J = 2.6, 2.0 Hz, pyrroleH), 3.63 (s, 3 H, NCH3), 
3.18 (s, 3 H, OCH3), 3.08 (dd, 2 H, J = 16.0 Hz, 2.7 Hz, CH2), 1.93 (t, 1 H, J = 
2.7 Hz, alkyne CH). 13C NMR (101 MHz, CDCl3) δ 144.0, 127.5, 127.1, 126.8, 
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125.5, 121.6, 121.3, 108.6, 80.8, 79.5, 70.8, 51.0, 36.2, 30.8. IR 3288 (w), 3287 (w), 3057 (w), 
2938 (w), 2918 (w), 2823 (w), 1544 (w), 1509 (w), 1492 (w), 1472 (w), 1447 (w), 1422 (w), 
1263 (w), 1200 (w), 1166 (m), 1089 (s), 1033 (w), 1015 (w), 864 (w), 785 (m), 765 (m), 707 
(s). HRMS (ESI) calcd for C16H18NO
+ [M+H]+ 240.1383; found 240.1378. 
3-(2-Methoxyhex-4-yn-2-yl)-1-methyl-1H-pyrrole (9g) 
 
Starting from 9e (340 mg, 1.92 mmol, 1.0 equiv) and following the conditions described for 
9b, the crude product was purified by flash column chromatography (Pentane/EtOAc= 25:1, 
1 % Et3N) to afford 9g as yellow oil (192 mg, 1.00 mmol, 52 %) 
Rf (Pentane/EtOAc= 25:1): 0.5. 1H NMR (400 MHz, CDCl3) δ 6.54 (m, 2 H, pyrroleH), 6.10 
(m, 1 H, pyrroleH), 3.63 (s, 3 H, NCH3), 3.09 (s, 3 H, OCH3), 2.64 (m, 2 H, CH2), 1.80 (t, 3 H, 
J = 2.6 Hz, alkyne CH3), 1.56 (s, 3 H, CH3COCH3). 
13C NMR (101 MHz, CDCl3) δ 127.1, 
121.6, 119.7, 107.1, 77.4, 76.0, 75.1, 50.4, 36.2, 32.1, 23.9, 3.8. IR 2979 (m), 2933 (w), 2910 
(w), 2820 (w), 1552 (w), 1509 (m), 1484 (w), 1423 (m), 1371 (m), 1307 (w), 1262 (m), 1237 
(w), 1208 (m), 1191 (m), 1152 (w), 1093 (s), 1069 (m), 965 (w), 914 (m), 832 (w), 814 (w), 
783 (s), 755 (w), 737 (m), 705 (w). HRMS (ESI) calcd for C12H17NNaO
+ [M+Na]+ 214.1202; 
found 214.1200. 
Methylpent-4-yn-2-yl)-1-methyl-1H-pyrrole (9h) 
616 mg of the corresponding ketone (5.00 mmol) and 3-bromobut-1-yne (864 
mg, 6.50 mmol) were used to obtain the crude propargylic alcohol (777 mg, 
4.76 mmol, <95%), which was used directly in the methylation step. 9h was 
obtained as yellow oil (551 mg, 2.88 mmol, 58% over two steps, dr=2:1, 
obtained by integration of the 1H NMR peaks at 6.11 and 6.04). 
  
Rf (Pentane / EtOAc = 25 / 1): 0.5. 1H NMR (400 MHz, CDCl3) δ 6.57 (t, 1 H, 
J = 2.1 Hz, pyrroleH major diastereoisomer), 6.54 (t, 1.5 H, J = 2.1 Hz, pyrroleH major and 
minor diastereoisomer), 6.48 (t, 0.5 H, J = 2.1 Hz, pyrroleH minor diastereoisomer), 6.11 (dd, 
1 H, J = 2.7, 1.8 Hz, pyrroleH major diastereoisomer), 6.04 (dd, 0.5 H, J = 2.7, 1.8 Hz, 
pyrroleH minor diastereoisomer), 3.62 (s, 3 H, NCH3 major diastereoisomer), 3.60 (s, 1 H, 
NCH3 minor diastereoisomer), 3.12 (s, 1 H, OCH3 minor diastereoisomer), 3.08 (s, 3 H, OCH3 
major diastereoisomer), 2.89 (m, 1.5 H, CH3CH major and minor diastereoisomer), 2.11 (d, 
0.5 H, J = 2.5 Hz, alkyne CH minor diastereoisomer), 2.01 (d, 1 H, J = 2.5 Hz, alkyne CH 
major diastereoisomer), 1.53 (two s, 4.5 H, CH3OMe major and minor diastereoisomer), 1.23 
(d, 3 H, J = 7.0 Hz, CH3CH major diastereoisomer), 1.03 (d, 1.5 H, J = 7.0 Hz, CH3CH minor 
diastereoisomer). 13C NMR (101 MHz, CDCl3) δ 126.0, 124.9, 121.4, 121.1, 120.4, 120.3, 
107.5, 107.4, 87.2, 86.9, 77.9, 77.2, 69.6, 69.5, 50.1, 50.0, 37.5, 36.8, 36.0, 35.9, 19.6, 18.2, 
16.6, 15.6. IR 3308 (w), 2983 (w), 2982 (w), 2940 (w), 1508 (w), 1374 (w), 1219 (w), 1196 
(w), 1089 (w), 1074 (w), 909 (s), 780 (w), 729 (s), 706 (w). HRMS (ESI) calcd for 
C12H17NNaO
+ [M+Na]+ 214.1202; found 214.1204. 
3-(1-Methoxybut-3-yn-1-yl)-1-methyl-1H-indole (9i) 
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970 mg of the corresponding aldehyde (6.09 mmol) was used to obtain the 
crude propargylic alcohol (1.03 g, 5.14 mmol, <84%). 398 mg of crude 
propargylic alcohol (2.00 mmol) was used for methylation. 9i was obtained 
as a yellow oil (372 mg, 1.74 mmol, 73% over two steps).  
Rf (Pentane / EtOAc = 15 / 1): 0.2. 1H NMR (400 MHz, CDCl3) δ 7.85 (m, 
1 H, benzeneH), 7.40-7.32 (m, 2 H, benzeneH), 7.23 (m, 1 H, benzeneH), 
7.14 (s, 1 H, pyrroleH), 4.79 (t, 1 H, J = 6.5 Hz, CHOCH3 ), 3.80 (s, 3 H, 
NCH3), 3.42 (s, 3 H, OCH3), 2.95 (ddd, 2 H, J = 16.8, 6.3, 2.7 Hz, CH2), 2.11 (t, 1 H, J = 2.6 
Hz, alkyne CH). 13C NMR (101 MHz, CDCl3) δ 137.0, 127.2, 126.2, 121.6, 119.5, 119.1, 
113.5, 109.2, 81.6, 75.7, 69.6, 56.2, 32.5, 26.7. IR 3308 (w), 2341 (w), 1473 (w), 1378 (w), 
1331 (w), 1243 (w), 1096 (m), 1068 (w), 907 (s), 726 (s), 685 (w), 672 (w), 660 (m), 634 (m). 
HRMS (ESI) calcd for C14H15NNaO
+ [M+Na]+ 236.1046; found 236.1048. 
5-methoxy-3-(1-methoxybut-3-yn-1-yl)-1-methyl-1H-indole (9j) 
250 mg of the corresponding aldehyde (1.32 mmol) was used to 
obtain the crude propargylic alcohol (280 mg, 1.22 mmol, <92%), 
which was used directly in the methylation step. 9j was obtained as a 
yellow oil (264 mg, 1.09 mmol, 83 % over two step).  
Rf (Pentane / EtOAc = 25 / 1): 0.3. 1H NMR (400 MHz, CDCl3) δ 
7.21-7.18 (m, 2H, benzeneH), 7.04 (s, 1 H, pyrroleH), 6.91 (dd, 1 H, J 
= 8.8, 2.5 Hz, benzeneH), 4.65 (t, 1 H, J = 6.6 Hz, CHOCH3), 3.86 (s, 3 H, NCH3), 3.75 (s, 3 
H, OCH3), 3.33 (s, 3 H, CHOCH3), 2.84 (ddd, 2 H, J = 16.4, 6.1, 2.7 Hz, CH2), 2.02 (t, 1 H, J 
= 2.6 Hz, alkyne CH). 13C NMR (101 MHz, CDCl3) δ 153.9, 132.6, 127.9, 126.6, 113.1, 
112.1, 110.1, 101.5, 81.8, 75.9, 69.6, 56.3, 55.9, 32.9, 26.7. IR 3291 (w), 3284 (w), 2989 (w), 
2975 (w), 2935 (w), 2852 (w), 1623 (w), 1578 (w), 1548 (w), 1491 (s), 1456 (m), 1425 (m), 
1325 (w), 1267 (w), 1224 (s), 1174 (w), 1138 (w), 1123 (w), 1096 (s), 1065 (m), 1035 (w), 
912 (w), 875 (w), 819 (w), 797 (m), 734 (m). HRMS (ESI) calcd for C15H17NNaO2
+ [M+Na]+ 
266.1151; found 266.1162. 
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4. Cyclization-alkynylation domino process.  
Optimization of the reaction: 
A solution of 6a (0.1 mmol, 1.0 equiv) in solvent (0.5 mL) was added into a solution of 
catalyst (0.03 mmol, 0.1 equiv), base (0.060 mmol, 2.0 equiv) and hypervalent iodine reagent 
(0.600 mmol, 2 equiv) in solvent (0.5 mL). The reaction was stopped after 72 h. The solvent 
was removed under vaccum, and the crude product was purified by column chromatography 
(Pentane/DCM= 15:1) directly without any further work-up. 
 
 
Entry Pyrrole Cat Reagent Base Solvent Yield* 
1 5 PPh3AuCl/AgOTf 1a Na2CO3 CH3CN <5% 
2 5 AuCl3/AgOTf 1a Na2CO3 CH3CN <5% 
3 5 AuCl3 1a Na2CO3 CH3CN <5% 
4 5 AuCl3† 1a Na2CO3 CH3CN <5% 
5 5 Au(OAc)3† 1a Na2CO3 CH3CN <5% 
6 5 35† 1a Na2CO3 CH3CN <5% 
7 5 36† 1a Na2CO3 CH3CN <5% 
8 5 PtCl2 1a Na2CO3 CH3CN 13% 
9 5 PtCl2/ AgOTf 1a Na2CO3 CH3CN <5% 
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10 5 PtCl2/bipyridine 1a Na2CO3 CH3CN <5% 
11 5 Pt(NH3)2Cl2 1a Na2CO3 CH3CN <5% 
12 5 PtCl2(COD) 1a Na2CO3 CH3CN <5% 
13 5 PtCl2 1a 2.6-lutidine CH3CN 13% 
14 5 PtCl2 1a Na3PO4 CH3CN 15% 
15 5 PtCl2 1a KHCO3 CH3CN <5% 
16 5 PtCl2 1a NaOAc CH3CN <5% 
17 5 PtCl2 1a NaHCO3 CH3CN 40% 
18 5 PtCl2 1a NaHCO3 Toluene 30% 
19 5 PtCl2 1a NaHCO3 THF 21% 
20 5 PtCl2 1a NaHCO3 MeOH 14% 
21 5 PtCl2 1b NaHCO3 CH3CN 27% 
22 5 PtCl2 1c NaHCO3 CH3CN <5% 
23 5 PtCl4 1a NaHCO3 CH3CN <5% 
24 5 Pt(PPh3)4 1a NaHCO3 CH3CN <5% 
25 6a PtCl2 1a NaHCO3 CH3CN 91%‡ 
26 7 PtCl2 1a NaHCO3 CH3CN 80% 
27 7 (IPr)AuCl/AgNTf2 1a NaHCO3 CH3CN <5% 
28 6a PtBr2 1a NaHCO3 CH3CN 98%‡ 
29 6a PtI2 1a NaHCO3 CH3CN <5% 
30 6a PtBr2 1a NaHCO3 CH3CN/C6H5Cl 
(v/v = 1/5) 
45% 
31 6a PtBr2 1a NaHCO3 CH3CN/THF 
(v/v = 1/5) 
96% 
32 6a PtBr2 1a NaHCO3 CH3CN/THF 
(v/v = 1/10) 
93% 
*Isolated yields were given. † The reaction was performed at 80 oC. ‡Not reproducible.  
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General procedure for cyclization-alkynylation domino process.  
A solution of 6 or 9 (0.30 mmol, 1.0 equiv) in THF (1.5 mL) was added into a solution of 
PtBr2 (11 mg, 0.030 mmol, 0.1 equiv), NaHCO3 (50 mg, 0.060 mmol, 2.0 equiv) and 1-
[(triisopropylsilyl)ethynyl]-3,3-bis(trifluoromethyl)-3(1H)-1,2-benziodoxole (1a) (330 mg, 
0.600 mmol, 2 equiv) in THF (1.0 mL) and CH3CN (0.5 mL). The reaction was stopped after 
72h- 120h. The solution was removed under vaccum, and the crude product was purified by 
column chromatography (Pentane/DCM) directly without any further work-up. 
1-Methyl-5-((triisopropylsilyl)ethynyl)-1H-indole (8a) 
 
Starting from 6a (49 mg, 0.30 mmol), the crude product was purified by column 
chromatography (Pentane/DCM= 15:1) to afford 8a as yellow oil (79 mg, 0.25 mmol, 84%) 
Rf (Pentane / DCM= 15 / 1): 0.5. 1H NMR (400 MHz, CDCl3) δ 7.79 (d, 1 H, J = 0.7 Hz, 
benzeneH), 7.34 (dd, 1 H, J = 8.5, 1.4 Hz, benzeneH), 7.23 (d, 1 H, J = 8.5 Hz, benzeneH), 
7.05 (d, 1 H, J = 3.1 Hz, pyrroleH), 6.45 (dd, 1 H, J = 3.1, 0.7 Hz, pyrroleH), 3.78 (s, 3 H, 
CH3), 1.23 (m, 21 H, TIPS). 
13C NMR (101 MHz, CDCl3) δ 136.3, 129.7, 128.1, 125.5, 125.2, 
114.1, 109.1, 109.0, 101.2, 87.0, 32.8, 18.7, 11.4. IR 2941 (m), 2863 (m), 2145 (m), 1616 (w), 
1514 (w), 1487 (m), 1464 (m), 1423 (w), 1381 (w), 1333 (w), 1283 (w), 1147 (w), 1078 (w), 
1014 (w), 996 (w), 945 (w), 919 (w), 884 (s), 820 (s), 802 (m), 717 (s), 710 (s). HRMS (ESI) 
calcd for C20H30NSi
+ [M+H]+ 312.2142; found 312.2145.  
Confirmation of the structure of 1-methyl-5-((triisopropylsilyl)ethynyl)-1H-indole (8a) 
by Sonogashira coupling 
 
37 (219 mg, 1.20 mmol, 1.2 equiv) was added into a solution of 36 (242 mg, 1.00 mmol, 1.1 
equiv), Pd(PPh3)Cl2 (35 mg, 0.050 mmol, 0.05 equiv) and CuI (38 mg, 0.20 mmol, 0.2 equiv) 
in degazed dioxane (2 mL). The mixture was kept overnight at 80 ˚C. The reaction was 
filtered through a plug of celite and the crude was purified by column chromatography 
(Pentane/DCM= 15:1) to afford 8a as yellow oil (290 mg, 0.930 mmol, 90%).  
Rf (Pentane / DCM= 15 / 1): 0.5. 1H NMR (400 MHz, CDCl3) δ 7.86 (d, 1 H, J = 0.7 Hz, 
benzeneH), 7.39 (dd, 1 H, J = 8.5, 1.4 Hz, benzeneH), 7.24 (d, 1 H, J = 8.5 Hz, benzeneH), 
7.06 (d, 1 H, J = 3.1 Hz, pyrroleH), 6.49 (dd, 1 H, J = 3.1, 0.7 Hz, pyrroleH), 3.77 (s, 3 H, 
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CH3), 1.23 (m, 21 H, TIPS). 
13C NMR (101 MHz, CDCl3) δ 136.3, 129.7, 128.1, 125.5, 125.2, 
114.1, 109.1, 109.0, 101.2, 87.0, 32.8, 18.7, 11.4. IR 2941 (m), 2863 (m), 2145 (m), 1616 (w), 
1514 (w), 1487 (m), 1464 (m), 1423 (w), 1381 (w), 1333 (w), 1283 (w), 1147 (w), 1078 (w), 
1014 (w), 996 (w), 945 (w), 919 (w), 884 (s), 820 (s), 802 (m), 717 (s), 710 (s). HRMS (ESI) 
calcd for C20H30NSi
+ [M+H]+ 312.2142; found 312.2150.  
1-(p-Tolyl)-5-((triisopropylsilyl)ethynyl)-1H-indole (8b) 
 
 
Starting from 6b (72 mg, 0.30 mmol), the crude product was purified by column 
chromatography (Pentane/DCM= 15:1) to afford 8b was obtained as yellow oil (94 mg, 0.24 
mmol, 81%). 
Rf (Pentane / DCM= 15 / 1): 0.5. 1H NMR (400 MHz, CDCl3) δ 7.85 (d, 1 H, J = 0.8 Hz, 
benzeneH), 7.42 (m, 1 H, benzeneH), 7.35 (m, 4 H, benzeneH), 7.31 (d, 2 H, J = 3.0 Hz, 
benzene + pyrroleH), 6.63 (d, 1 H, J = 3.0 Hz, pyrroleH), 2.44 (s, 3 H, CH3), 1.15 (m, 21 H, 
TIPS). 13C NMR (101 MHz, CDCl3) δ 136.9, 136.6, 135.6, 130.2, 129.0, 128.9, 126.2, 125.4, 
124.3, 115.1, 110.3, 108.7, 103.3, 87.5, 21.1, 18.7, 11.4. IR 2944 (w), 2865 (w), 2149 (w), 
1611 (w), 1520 (m), 1471 (m), 1336 (w), 1222 (w), 884 (w), 806 (w), 762 (w), 743 (w), 721 
(w), 680 (m), 660 (w), 647 (w), 631 (w), 618 (w).  HRMS (ESI) calcd for C26H34NSi
+ [M+H]+ 
388.2455; found 388.2460. 
1-Benzyl-5-((triisopropylsilyl)ethynyl)-1H-indole (8c) 
 
Starting from 6c (76 mg, 0.30 mmol), the crude product was purified by column 
chromatography (Pentane/DCM= 30:1) to afford 8c as yellow oil (96 mg, 0.25 mmol, 83%). 
Rf (Pentane / DCM= 30 / 1): 0.4. 1H NMR (400 MHz, CDCl3) δ 7.84 (dd, 1 H, J = 1.4, 0.6 Hz, 
benzeneH), 7.30 (m, 4 H, benzeneH), 7.19 (d, 1 H, J = 8.5 Hz, benzeneH), 7.14 (d, 1 H, J = 
3.1 Hz, pyrroleH), 7.07 (m, 2 H, benzeneH), 6.53 (dd, 1 H, J = 3.1, 0.6 Hz, pyrroleH), 5.31 (s, 
2 H, CH2), 1.17 (m, 21 H, TIPS). 
13C NMR (101 MHz, CDCl3) δ 137.2, 135.9, 129.2, 128.8, 
128.5, 127.7, 126.6, 125.8, 125.3, 114.5, 109.6, 108.9, 102.0, 87.2, 50.2, 18.7, 11.4. IR 2958 
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(m), 2942 (s), 2928 (m), 2892 (m), 2865 (s), 2148 (m), 1667 (w), 1512 (w), 1496 (w), 1480 
(m), 1464 (m), 1457 (m), 1391 (w), 1356 (w), 1331 (w), 1265 (m), 1234 (w), 1215 (w), 1077 
(w), 1016 (w), 998 (w), 946 (w), 884 (m), 824 (m), 803 (w), 777 (w), 761 (m), 741 (s), 731 (s). 
HRMS (ESI) calcd for C26H34NSi
+ [M+H]+ 388.2455; found 388.2460. 
1-(3-Methoxypropyl)-5-((triisopropylsilyl)ethynyl)-1H-indole (8d) 
 
Starting from 6d (66 mg, 0.30 mmol), the crude product was purified by column 
chromatography (Pentane/DCM= 10:1) to afford 8d as yellow oil (89 mg, 0.24 mmol, 80%). 
Rf (Pentane / DCM= 10 / 1): 0.1. 1H NMR (400 MHz, CDCl3) δ 7.81 (d, 1 H, J = 0.6 Hz, 
benzeneH), 7.34 (dd, 1 H, J = 8.5 Hz, 1.5 Hz, benzeneH), 7.28 (d, 1 H, J = 8.5 Hz, benzeneH), 
7.10 (d, 1 H, J = 3.1 Hz, pyrroleH), 6.47 (dd, 1 H, J = 3.1 Hz, 0.7 Hz, pyrroleH), 4.25 (t, 1 H, 
J = 6.7 Hz, NCH2), 3.32 (s, 3 H, OCH3), 3.24 (t, 2 H, J = 5.8 Hz, CH2OCH3), 2.04 (m, 2 H,  
CH2), 1.17 (m, 21 H, TIPS). 
13C NMR (101 MHz, CDCl3) δ 135.7, 128.9, 128.2, 125.5, 125.3, 
114.1, 109.2, 109.0, 101.4, 87.0, 68.8, 58.6, 42.9, 30.3, 18.7, 11.4. IR 2942 (s), 2890 (m), 
2865 (s), 2812 (w), 2147 (s), 1513 (w), 1482 (s), 1463 (m), 1392 (w), 1352 (w), 1332 (w), 
1254 (w), 1237 (w), 1207 (w), 1121 (s), 1076 (w), 1015 (w), 996 (w), 946 (w), 915 (w), 884 
(s), 821 (s), 804 (m), 763 (w), 722 (m). HRMS (ESI) calcd for C23H36NOSi
+ [M+H]+ 
370.2561; found 370.2552.  
1-(4,4,4-Trifluorobutyl)-5-((triisopropylsilyl)ethynyl)-1H-indole (8e) 
 
Starting from 6e (83 mg, 0.30 mmol), the crude product was purified by column 
chromatography (Pentane/DCM= 30:1) to afford 8e as yellow oil (100 mg, 0.250 mmol, 82%). 
Rf (Pentane / DCM= 30 / 1): 0.2. 1H NMR (400 MHz, CDCl3) δ 7.82 (m, 1 H, benzeneH), 
7.36 (dd, 1 H, J = 8.5, 1.4 Hz, benzeneH), 7.22 (d, 1 H, J = 8.5 Hz, benzeneH), 7.08 (d, 1 H, J 
= 3.1 Hz, pyrroleH), 6.50 (d, 1 H, J = 3.1 Hz, pyrroleH), 4.20 (t, 3 H, J = 6.5 Hz, NCH2), 2.07 
(m, 4 H, CH2CH2CF3), 1.15 (m, 21 H, TIPS). 
13C NMR (101 MHz, CDCl3) δ 135.5, 128.4, 
128.3, 126.8 (q, J = 275.8 Hz) 125.8, 125.5, 114.6, 108.9, 108.7, 102.1, 87.4, 44.9, 31.0 (q, J 
= 29.3 Hz), 22.9 (q, J = 2.9 Hz), 18.7, 11.4. IR 2943 (m), 2869 (m), 2235 (w), 1687 (w), 1675 
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(w), 1674 (w), 1617 (w), 1466 (w), 1466 (w), 1325 (s), 1168 (m), 1101 (s), 1067 (s), 1012 (m), 
927 (w), 883 (m), 840 (m), 809 (w), 735 (s). HRMS (ESI) calcd for C23F3H33NSi
+ [M+H]+ 
408.2329; found 408.2338. 
1,4-Dimethyl-5-((triisopropylsilyl)ethynyl)-1H-indole (8f) 
 
Starting from 6f (53 mg, 0.30 mmol), the crude product was purified by column 
chromatography (Pentane/DCM= 20:1) to afford 8f as yellow oil (68 mg, 0.21 mmol, 70%). 
Rf (Pentane / DCM= 20 / 1): 0.4. 1H NMR (400 MHz, CDCl3) δ 7.36 (d, 1 H, J = 8.5 Hz, 
benzeneH), 7.10 (d, 1 H, J = 8.5 Hz, benzeneH), 7.05 (d, 1 H, J = 3.1 Hz, pyrroleH), 6.52 (d, 
1 H, J = 3.1, pyrroleH), 3.77 (s, 3 H, NCH3), 2.71 (s, 3 H, CH3), 1.19 (s, 21 H, TIPS). 
13C 
NMR (101 MHz, CDCl3) δ 136.0, 133.9, 128.9, 128.3, 126.2, 113.5, 107.6, 106.7, 100.2, 91.2, 
32.9, 18.8, 17.2, 11.5. IR 2941 (s), 2925 (m), 2891 (m), 2863 (s), 2144 (s), 1517 (w), 1483 
(m), 1463 (m), 1421 (w), 1379 (w), 1366 (w), 1335 (w), 1283 (m), 1236 (w), 1152 (w), 1090 
(w), 1071 (w), 1014 (w), 996 (w), 911 (m), 882 (s), 816 (s). HRMS (ESI) calcd for 
C21H32NSi
+ [M+H]+ 326.2299; found 326.2301. 
1-Methyl-4-phenyl-5-((triisopropylsilyl)ethynyl)-1H-indole (8g) 
 
Starting from 6g (72 mg, 0.30 mmol), the crude product was purified by column 
chromatography (Pentane/DCM= 50:1) to afford 8g as yellow oil (65 mg, 0.17 mmol, 56%). 
The ratio of regioisomers (8g:10c = 4:1) was determined on the 1H NMR spectrum of the 
crude reaction mixture (Comparing two peaks at δ 6.51 and δ 6.39). 
Rf (Pentane / DCM= 50 / 1): 0.5. 1H NMR (400 MHz, CDCl3) δ 7.53 (d, 1 H, J = 8.2 Hz, 
benzeneH), 7.38 (m, 5 H, benzeneH), 7.30 (d, 1 H, J = 8.2 Hz, benzeneH), 6.97 (d, 1 H, J = 
3.1 Hz, pyrroleH), 6.49 (d, 1 H, J = 3.1 Hz, benzeneH), 3.16 (s, 3 H, NCH3), 0.92 (m, 21 H, 
TIPS). 13C NMR (101 MHz, CDCl3) δ 138.4, 133.8, 132.2, 130.7, 129.7, 129.5, 127.5, 127.4, 
123.9, 119.8, 117.0, 107.5, 101.1, 92.0, 36.6, 18.6, 11.2. IR 2942 (m), 2891 (w), 2864 (m), 
2145 (w), 1519 (w), 1464 (w), 1314 (w), 1095 (w), 1017 (w), 997 (w), 962 (w), 884 (w), 814 
(w), 761 (w), 712 (m). HRMS (ESI) calcd for C26H33NSi [M]
+ 387.2382; found 387.2376. 
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1-Methyl-4-(p-tolyl)-5-((triisopropylsilyl)ethynyl)-1H-indole (8h) 
 
Starting from 6h (76 mg, 0.30 mmol), the crude product was purified by column 
chromatography (Pentane/DCM= 15:1) to afford 8h as yellow oil (63 mg, 0.16 mmol, 52%). 
The ratio of regioisomeres (8h:10k = 3:1)  were determined by the spectra of crude product. 
The ratio of regioisomers was determined on the 1H NMR spectrum of the crude reaction 
mixture (Comparing two peaks at δ 6.42 and δ 6.30).. 
Rf (Pentane / DCM= 15 / 1): 0.4. 1H NMR (400 MHz, CDCl3) δ 7.47 (d, 1 H, J = 8.2 Hz, 
benzeneH), 7.24 (m, 3 H, benzeneH), 7.14 (m, 2 H, benzeneH), 6.93 (d, 1 H, J = 3.1 Hz, 
pyrroleH), 6.44 (d, 1 H, J = 3.1 Hz, pyrroleH), 3.16 (s, 3 H, NCH3), 2.36 (s, 3 H, CH3), 0.89 
(m, 21 H, TIPS). 13C NMR (101 MHz, CDCl3) δ 136.9, 135.4, 133.9, 132.1, 130.5, 129.8, 
129.5, 128.2, 123.8, 119.6, 117.2, 107.6, 101.1, 91.7, 36.6, 21.2, 18.5, 11.3. IR 3298 (w), 
2984 (w), 2938 (m), 2868 (w), 2826 (w), 1713 (w), 1459 (w), 1105 (s), 1009 (w), 760 (m).  
HRMS (ESI) calcd for C27H36NSi
+ [M+H]+ 402.2612; found 402.2605. 
4-(4-Bromophenyl)-1-methyl-5-((triisopropylsilyl)ethynyl)-1H-indole (8i) 
 
 
Starting from 6i (95 mg, 0.30 mmol), the crude product was purified by column 
chromatography (Pentane/DCM= 30:1) to afford 8i as yellow oil (62 mg, 0.14 mmol, 44%). 
The ratio of regioisomeres (8i:10l = 2.5:1) was determined on the 1H NMR spectrum of the 
crude reaction mixture (Comparing the two peaks at δ 6.49 and δ 6.30). 
Rf (Pentane / DCM= 30 / 1): 0.3. 1H NMR (400 MHz, CDCl3) δ 7.53 (d, 3 H, J = 8.2 Hz, Ar 
H), 7.29 (dd, 3 H, J = 8.4, 1.5 Hz, Ar H), 6.98 (d, 1 H, J = 3.1 Hz, Ar H), 6.49 (d, 1 H, J = 3.1 
Hz, Ar H), 3.21 (s, 3 H, NCH3), 0.95 (m, 21 H, TIPS). 
13C NMR (101 MHz, CDCl3) δ 137.6, 
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133.6, 132.4, 132.3, 130.8, 129.7, 128.1, 123.9, 121.8, 120.2, 117.1, 107.1, 101.3, 92.6, 36.8, 
18.5, 11.2. IR 2945 (s), 2891 (w), 2864 (s), 2390 (w), 2358 (w), 2342 (w), 2297 (w), 2143 (w), 
1516 (w), 1464 (m), 1316 (w), 1097 (w), 1072 (w), 1016 (w), 963 (w), 915 (w), 885 (w), 819 
(s), 730 (s), 717 (m). HRMS (ESI) calcd for C26H33BrNSi
+ [M+H]+ 466.1560; found 
466.1556. 
 
1-Methyl-4-(naphthalen-1-yl)-5-((triisopropylsilyl)ethynyl)-1H-indole (8j) 
Starting from 6i (87 mg, 0.30 mmol), the crude product was purified by column 
chromatography (Pentane/DCM= 10:1) to afford 8j as yellow oil (41 mg, 0.094 mmol, 31%) 
and 10d as yellow oil (41mg, 0.094 mmol, 31%). 
8j 
Rf (Pentane / DCM= 15 / 1): 0.6. 1H NMR (400 MHz, CDCl3) δ 7.78-7.74 (m, 2 H, 
benzeneH), 7.44-7.38 (m, 4 H, benzeneH), 7.31 (m, 1 H, benzeneH), 7.24-7.18 (m, 2H, 
benzeneH), 6.88 (d, 1 H, J = 3.1 Hz, pyrroleH), 5.88 (d, 1 H, J = 3.1 Hz, pyrroleH), 3.74 (s, 3 
H, NCH3), 0.65-0.60 (m, 21 H, TIPS). 
13C NMR (101 MHz, CDCl3) δ 137.4, 136.8, 136.1, 
133.7, 132.2, 129.5, 129.1, 127.9, 127.5, 127.4, 126.6, 126.3, 125.5, 125.3, 125.2, 114.6, 
108.4, 107.3, 101.5, 90.9, 33.0, 18.3, 11.0. IR 2944 (m), 2892 (w), 2891 (w), 2865 (w), 2864 
(w), 2362 (s), 2361 (s), 2148 (w), 1465 (w), 911 (w), 887 (w), 886 (w), 820 (w), 800 (w), 777 
(w), 734 (m). HRMS (ESI) calcd for C30H35NSi
+ [M]+ 438.2612; found 438.2605. 
10d 
Rf (Pentane / DCM= 15 / 1): 0.5. 1H NMR (400 MHz, CDCl3) δ 7.89-7.86 (m, 2 H, 
benzeneH), 7.62 (d, 1 H, J = 8.2 Hz，benzeneH), 7.53-7.49 (m, 2 H，benzeneH), 7.45-7.30 
(m, 4 H，benzeneH), 6.93 (d, 1 H, J = 3.1 Hz，pyrroleH), 6.53 (d, 1 H, J = 3.1 Hz，
pyrroleH), 2.88 (s, 3 H, NCH3), 0.70 (m, 21 H, TIPS). 
13C NMR (101 MHz, CDCl3) δ 136.1, 
134.6, 133.6, 133.4, 132.0, 129.5, 128.4, 128.0, 127.9, 127.5, 126.6, 126.1, 125.7, 124.9, 
123.9, 120.1, 117.8, 107.2, 101.1, 91.8, 35.6, 18.3, 11.0. IR 3055 (w), 2942 (s), 2892 (m), 
2863 (s), 2145 (m), 1514 (w), 1464 (m), 1410 (w), 1409 (w), 1387 (w), 1314 (w), 1234 (w), 
1082 (w), 1016 (w), 996 (w), 956 (m), 911 (m), 884 (m), 804 (s), 778 (m), 732 (s), 716 (s). 
HRMS (ESI) calcd for C30H35NSi
+ [M]+ 438.2612; found 438.2608. 
1,6-Dimethyl-5-((triisopropylsilyl)ethynyl)-1H-indole (8k) 
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Starting from 6k (52 mg, 0.30 mmol), the crude product was purified by column 
chromatography (Pentane/DCM= 15:1) to afford 8k as yellow oil (73 mg, 0.22 mmol, 
75%).[10] 
Rf (Pentane / DCM= 15 / 1): 0.4.1H NMR (400 MHz, CDCl3) δ 7.79 (s, 1 H, benzeneH), 7.13 
(s, 1 H, benzeneH), 6.98 (d, 1 H, J = 3.1 Hz, pyrroleH), 6.40 (dd, 1 H, J = 3.1, 0.7 Hz, 
pyrroleH), 3.74 (s, 3 H, NCH3), 2.60 (s, 3 H, CH3), 1.16 (m, 21 H, TIPS). 
13C NMR (101 
MHz, CDCl3) δ 136.8, 133.7, 129.1, 126.3, 125.5, 114.9, 109.5, 107.6, 100.9, 91.0, 32.8, 21.6, 
18.8, 11.5. IR 2943 (s), 2893 (m), 2865 (s), 2143 (s), 1622 (w), 1514 (w), 1477 (m), 1425 (w), 
1377 (w), 1326 (w), 1271 (w), 1238 (w), 1076 (w), 1013 (w), 997 (w), 913 (w), 885 (m), 845 
(m), 818 (w), 741 (w), 720 (m). HRMS (ESI) calcd for C21H32NSi
+ [M+H]+ 326.2299; found 
326.2303. 
1,4-Dimethyl-6-((triisopropylsilyl)ethynyl)-1H-indole (10e) 
 
Starting from 6l (52 mg, 0.30 mmol), the crude product was purified by column 
chromatography (Pentane/DCM= 20:1) to afford 10e as yellow oil (53 mg, 0.16 mmol, 54%). 
Rf (Pentane / DCM= 20 / 1): 0.5. 1H NMR (400 MHz, CDCl3) δ 7.33 (s, 1 H, benzeneH), 7.08 
(d, 1 H, J = 3.1 Hz, pyrroleH), 7.04 (s, 1 H, benzeneH), 6.46 (dd, 1 H, J = 3.1, 0.8 Hz, 
pyrroleH), 3.78 (s, 3 H, NCH3), 2.51 (s, 3 H, CH3), 1.16 (s, 21 H, TIPS). 
13C NMR (101 MHz, 
CDCl3) δ 135.9, 130.1, 129.6, 128.7, 123.4, 116.2, 110.9, 109.2, 99.8, 87.8, 33.0, 18.8, 18.5, 
11.5. IR 2957 (w), 2942 (m), 2927 (w), 2889 (w), 2865 (m), 2144 (w), 1510 (w), 1463 (w), 
1299 (w), 884 (w), 767 (w), 740 (w), 710 (m), 682 (m), 671 (m), 659 (w), 648 (w), 637 (s), 
617 (w). HRMS (ESI) calcd for C21H32NSi
+ [M+H]+ 326.2299; found 326.2302. 
9-Methyl-3-((triisopropylsilyl)ethynyl)-9H-carbazole (8m) 
 
                                                          
[10] The product contains  about 5 % impurity. 
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Starting from 6m (64 mg, 0.30 mmol), the crude product was purified by column 
chromatography (Pentane/DCM= 50:1) to afford 8m as yellow oil (82 mg, 0.23 mmol, 76%). 
Rf (Pentane / DCM= 50 / 1): 0.3. 1H NMR (400 MHz, CDCl3) δ 8.25 (m, 1 H, benzeneH), 
8.10 (d, 1 H, J = 7.8 Hz, benzeneH), 7.62 (dd, 1 H, J = 1.5, 8.4 Hz, benzeneH), 7.51 (m, 1 H，
benzeneH), 7.40 (m, 1 H, benzeneH), 7.31-7.28 (m, 2 H, benzeneH), 3.83 (s, 3 H, NCH3), 1.22 
(s, 21 H, TIPS). 13C NMR (101 MHz, CDCl3) δ 141.3, 140.5, 129.8, 126.1, 124.4, 122.6, 
122.3, 120.5, 119.3, 113.6, 108.7, 108.6, 108.2, 87.7, 29.1, 18.8, 11.5.  IR 2944 (w), 2891 (w), 
2890 (w), 2866 (w), 2865 (w), 2148 (w), 2147 (w), 1474 (w), 1249 (w), 907 (s), 730 (s).  
HRMS (ESI) calcd for C24H32NSi
+ [M]+ 362.2299; found 362.2291. 
4-Methyl-7-((triisopropylsilyl)ethynyl)-4H-thieno[3,2-b]indole (8n) 
 
Starting from 6n (66 mg, 0.30 mmol), the crude product was purified by column 
chromatography (Pentane/DCM= 20:1) to afford 8n as yellow oil (86 mg, 0.23 mmol, 78%). 
Rf (Pentane / DCM= 20 / 1): 0.4. 1H NMR (400 MHz, CDCl3) δ 7.92 (dd, 1 H, J = 1.4, 0.4 Hz, 
benzeneH), 7.43 (dd, 1 H, J = 8.5, 1.5 Hz, benzeneH), 7.40 (d, 1 H, J = 5.2 Hz, thiophenH), 
7.28 (dd, 1 H, J = 8.5, 0.4 Hz, benzeneH), 7.06 (d, 1 H, J = 5.2 Hz, thiophenH), 3.87 (s, 3 H, 
NCH3), 1.17 (s, 21 H, TIPS). 
13C NMR (101 MHz, CDCl3) δ 146.5, 141.5, 127.4, 126.5, 123.0, 
121.4, 115.8, 113.9, 110.0, 109.4, 108.6, 87.7, 31.3, 18.8, 11.5. IR 3298 (w), 2979 (w), 2934 
(w), 2914 (w), 1509 (w), 1422 (w), 1374 (w), 1256 (w), 1177 (w), 936 (w), 786 (m), 738 (w), 
706 (m), 695 (m), 681 (m), 653 (m), 646 (s), 623 (m), 607 (m). HRMS (ESI) calcd for 
C22H30NSSi
+ [M+H]+ 368.1863; found 368.1861. 
 
1-Methyl-6-((triisopropylsilyl)ethynyl)-1H-indole (10a) 
 
Starting from 9a (49 mg, 0.30 mmol), the crude product was purified by column 
chromatography (Pentane/DCM= 20:1) to afford 10a as yellow oil (72 mg, 0.23 mmol, 77%). 
Rf (Pentane / DCM= 20 / 1): 0.4. 1H NMR (400 MHz, CDCl3) δ 7.56 (d, 1 H, J = 8.2, 
benzeneH), 7.49 (s, 1 H, benzeneH), 7.26 (dd, 2 H, J = 8.2, 1.2 Hz, benzeneH), 7.09 (d, 1 H, J 
= 3.0 Hz, pyrroleH), 6.50 (d, 1 H, J = 3.0 Hz, pyrroleH), 3.79 (s, 3 H, NCH3), 1.17 (m, 21 H, 
TIPS). 13C NMR (101 MHz, CDCl3) δ 136.1, 130.2, 128.6, 123.5, 120.6, 116.1, 113.1, 109.0, 
101.2, 88.2, 32.9, 18.7, 11.4. IR 2943 (s), 2893 (m), 2865 (s), 2151 (m), 1511 (w), 1466 (s), 
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1421 (w), 1344 (w), 1245 (w), 1076 (w), 1012 (w), 944 (m), 885 (m), 857 (w), 816 (m), 763 
(w), 714 (s). HRMS (ESI) calcd for C20H30NSi
+ [M+H]+ 312.2142; found 312.2141. 
1,7-Dimethyl-6-((triisopropylsilyl)ethynyl)-1H-indole (10b) 
 
Starting from 9b (52 mg, 0.30 mmol), the crude product was purified by column 
chromatography (Pentane/DCM= 20:1) to afford 10b as yellow oil (48 mg, 0.15 mmol, 49%). 
Rf (Pentane / DCM= 50 / 1): 0.3. 1H NMR (400 MHz, CDCl3) δ 7.35 (d, 1 H, J = 8.2 Hz, 
benzeneH), 7.20 (d, 1 H, J = 8.2 Hz, benzeneH), 6.97 (d, 1 H, J = 3.1 Hz, pyrroleH), 6.39 (d, 
1 H, J = 3.1 Hz, pyrroleH), 4.06 (s, 3 H, NCH3), 2.95 (s, 3 H, CH3), 1.16 (s, 21 H, TIPS). 
13C 
NMR (101 MHz, CDCl3) δ 135.1, 132.1, 129.8, 124.5, 124.4, 118.5, 117.2, 107.8, 101.2, 92.5, 
37.4, 18.8, 16.9, 11.5. IR 2942 (s), 2892 (m), 2865 (s), 2147 (m), 1515 (w), 1464 (m), 1313 
(w), 1312 (w), 1001 (w), 911 (m), 887 (m), 886 (m), 813 (m), 730 (s).  HRMS (ESI) calcd for 
C21H32NSi
+ [M]+ 326.2299; found 326.2295. 
1-Methyl-7-phenyl-6-((triisopropylsilyl)ethynyl)-1H-indole (10c) 
 
Starting from 9c (72 mg, 0.30 mmol), the crude product was purified by column 
chromatography (Pentane/DCM= 20:1) to afford 10c as yellow oil (62 mg, 0.16 mmol, 53%). 
1H NMR (400 MHz, CDCl3) δ 7.53 (d, 1 H, J = 8.2 Hz, benzeneH), 7.42-7.35 (m, 5 H, 
benzeneH), 7.31 (d, 1 H, J = 8.2 Hz, benzeneH), 6.97 (d, 1 H, J = 3.1 Hz, pyrroleH), 6.49 (d, 
1 H, J = 3.1 Hz, pyrroleH), 3.16 (s, 3 H, NCH3), 0.93 (m, 21 H, TIPS). 
13C NMR (101 MHz, 
CDCl3) δ 138.4, 133.8, 132.2, 130.7, 129.7, 129.5, 127.5, 127.4, 123.9, 119.8, 117.0, 107.5, 
101.1, 92.0, 36.6, 18.6, 11.2. IR 2946 (w), 2866 (w), 2146 (w), 1465 (w), 1295 (w), 1273 (w), 
1203 (m), 965 (m), 906 (w), 883 (w), 814 (w), 763 (w), 712 (w).  HRMS (ESI) calcd for 
C26H33NSi
+ [M]+ 388.2455; found 388.2457.  
1-Methyl-7-(naphthalen-1-yl)-6-((triisopropylsilyl)ethynyl)-1H-indole (10d) 
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Starting from 9d (87 mg, 0.30 mmol), the crude product was purified by column 
chromatography (Pentane/DCM= 20:1) to afford 10d as yellow oil (62 mg, 0.14 mmol, 47%). 
Charactization datas corresonds to the one obtained starting from 6i. 
1,4-Dimethyl-6-((triisopropylsilyl)ethynyl)-1H-indole (10e) 
 
Starting from 9e (52 mg, 0.30 mmol), the crude product was purified by column 
chromatography (Pentane/DCM= 20:1) to afford 10e as yellow oil (53 mg, 0.16 mmol, 54%). 
Charactization datas corresponds to the one obtained starting from 6k. 
1-Methyl-4-phenyl-6-((triisopropylsilyl)ethynyl)-1H-indole (10f) 
 
Starting from 9f (72 mg, 0.30 mmol), the crude product was purified by column 
chromatography (Pentane/DCM= 15:1) to afford 10f as yellow oil (75 mg, 0.19 mmol, 65%). 
Rf (Pentane / DCM= 15 / 1): 0.4. 1H NMR (400 MHz, CDCl3) δ 7.70 (dd, 2 H, J = 8.4, 1.2 Hz, 
benzeneH), 7.49 (m, 3 H, benzeneH), 7.39 (m, 1 H, benzeneH), 7.33 (d, 1 H, J = 1.2 Hz, 
benzeneH), 7.14 (d, 1 H, J = 3.1 Hz, pyrroleH), 6.62 (dd, 1 H, J = 3.1, 0.8 Hz, pyrroleH), 3.83 
(s, 3 H, NCH3), 1.18 (s, 21 H, TIPS).
 13C NMR (101 MHz, CDCl3) δ 140.5, 136.7, 134.4, 
130.5, 128.7, 128.5, 127.2, 127.0, 123.3, 116.5, 112.2, 108.8, 100.9, 88.4, 33.1, 18.8, 11.5. IR 
2942 (s), 2891 (w), 2864 (s), 2148 (m), 1511 (m), 1499 (w), 1462 (m), 1431 (w), 1327 (w), 
1295 (w), 1264 (w), 1212 (w), 1091 (w), 1030 (w), 1017 (w), 971 (m), 920 (w), 883 (m), 850 
(w), 781 (m), 761 (w), 729 (w), 711 (m). HRMS (ESI) calcd for C26H34NSi
+ [M+H]+ 
388.2455; found 388.2466. 
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1,4,7-Trimethyl-6-((triisopropylsilyl)ethynyl)-1H-indole (10g) 
 
Starting from 9g (57 mg, 0.30 mmol), the crude product was purified by column 
chromatography (Pentane/DCM= 20:1) to afford 10g as yellow oil (45 mg, 0.13 mmol, 44%). 
Rf (Pentane / DCM= 20 / 1): 0.2. 1H NMR (400 MHz, CDCl3) δ 7.03 (s, 1 H, benzeneH), 6.97 
(d, 1 H, J = 3.1 Hz, pyrroleH), 6.41 (d, 1 H, J = 3.1 Hz, pyrroleH), 4.05 (s, 3 H, NCH3), 2.92 
(s, 3 H, CH3), 2.46 (s, 3 H, CH3), 1.17 (s, 21 H, TIPS). 
13C NMR (101 MHz, CDCl3) δ 134.8, 
131.5, 129.9, 127.6, 124.1, 122.0, 117.0, 108.0, 99.6, 92.1, 37.3, 18.8, 18.1, 16.6, 11.5. IR 
2958 (s), 2943 (s), 2926 (s), 2892 (m), 2865 (s), 2142 (s), 1517 (w), 1496 (w), 1463 (m), 1384 
(w), 1346 (w), 1303 (w), 1091 (w), 1065 (w), 1008 (w), 921 (w), 885 (s), 864 (w), 772 (w), 
744 (w), 709 (s). HRMS (ESI) calcd for C22H34NSi
+ [M+H]+ 340.2455; found 340.2460. 
1,4,5-Trimethyl-6-((triisopropylsilyl)ethynyl)-1H-indole (10h) 
 
Starting from 9h (57 mg, 0.30 mmol), the crude product was purified by column 
chromatography (Pentane/DCM= 30:1) to afford 10h as yellow oil (35 mg, 0.10 mmol, 34%). 
Rf (Pentane / DCM= 30 / 1): 0.2. 1H NMR (400 MHz, CDCl3) δ 7.36 (s, 1 H, benzeneH), 7.04 
(d, 1 H, J = 3.1 Hz, pyrroleH), 6.42 (dd, 1 H, J = 3.1, 0.8 Hz, pyrroleH), 3.75 (s, 3 H, NCH3), 
2.52 (s, 3 H, CH3), 2.45 (s, 3 H, CH3), 1.16 (s, 21 H, TIPS). 
13C NMR (201 MHz, CDCl3) δ 
134.2, 129.6, 129.5, 128.2, 127.8, 117.2, 111.3, 108.5, 99.5, 91.5, 32.9, 18.8, 17.0, 15.9, 11.5.  
HRMS IR 2942 (m), 2899 (w), 2140 (w), 1510 (w), 1283 (w), 1085 (w), 997 (w), 912 (w), 
885 (w), 849 (w), 714 (w). (ESI) calcd for C22H34NSi
+ [M+H]+ 340.2455; found 340.2462. 
9-Methyl-2-((triisopropylsilyl)ethynyl)-9H-carbazole (10i) 
 
Starting from 9i (64 mg, 0.30 mmol), the crude product was purified by column 
chromatography (Pentane/DCM= 30:1) to afford 10i as yellow oil (63 mg, 0.17 mmol, 58%). 
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Rf (Pentane / DCM= 30 / 1): 0.4. 1H NMR (400 MHz, CDCl3) δ 8.08 (d, 1 H, J = 7.8 Hz, 
benzeneH), 8.00 (d, 1 H, J = 8.0 Hz, benzeneH), 7.53 (s, 1 H, benzeneH), 7.50 (m, 1 H, 
benzeneH), 7.39 (m, 2 H, benzeneH), 7.25 (m, 1 H, benzeneH), 3.84 (s, 3 H, NCH3), 1.20 (s, 
21 H, TIPS). 13C NMR (101 MHz, CDCl3) δ 141.6, 140.5, 126.1, 123.1, 122.8, 122.4, 120.5, 
120.3, 120.0, 119.1, 112.1, 108.5, 108.4, 89.7, 29.1, 18.8, 11.4. IR 2957 (w), 2891 (w), 2865 
(w), 2150 (w), 1601 (w), 1498 (w), 1324 (m), 1248 (w), 1119 (w), 1018 (w), 940 (w), 909 (m), 
885 (w), 851 (w), 816 (w), 766 (w), 741 (s), 725 (m). HRMS (ESI) calcd for C24H32NSi
+ 
[M+H]+ 362.2299; found 362.2307. 
6-Methoxy-9-methyl-2-((triisopropylsilyl)ethynyl)-9H-carbazole (10j) 
 
Starting from 9j (73 mg, 0.30 mmol), the crude product was purified by column 
chromatography (Pentane/DCM= 30:1) to afford 10j was obtained as yellow oil (75 mg, 0.19 
mmol, 64%). 
Rf (Pentane / ether= 30 / 1): 0.5. 1H NMR (400 MHz, CDCl3) δ 7.95 (dd, 1 H, J = 8.0, 0.6 Hz, 
benzeneH), 7.55 (d, 1 H, J = 2.4 Hz, benzeneH), 7.49 (d, 1 H, J = 0.4 Hz, benzeneH), 7.31 (m, 
2 H, benzeneH), 7.13 (dd, 1 H, J = 8.8, 2.5 Hz, benzeneH), 3.93 (s, 3 H, NCH3), 3.82 (s, 3 H, 
OCH3), 1.18 (m, 21 H, TIPS). 
13C NMR (101 MHz, CDCl3) δ 153.8, 140.9, 136.8, 122.7, 
122.6, 120.2, 119.9, 115.5, 112.2, 109.3, 108.5, 103.3, 89.7, 77.2, 56.1, 29.7, 18.8, 11.4. IR 
2960 (w), 2186 (w), 1607 (w), 1509 (s), 1463 (w), 1438 (w), 1295 (m), 1250 (s), 1176 (m), 
1034 (m), 833 (s), 709 (w). HRMS (ESI) calcd for C25H34NOSi
+ [M+H]+ 392.2404; found 
392.2400. 
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5. Further functionalization: 
5-Ethynyl-1-methyl-1H-indole (39) 
 
TBAF (0.424 mL, 0.424 mmol, 1.2 equiv) was added slowly into a solution of 8a (110 mg, 
0.353 mmol, 1.0 equiv) in THF (4 mL) at 0 °C. The reaction was quenched with sat NH4Cl 
solution (20 mL) after 30 min. The aqueous and organic layers were separated and the 
aqueous layer was extracted with ether (3x10 mL). After drying over MgSO4 and 
concentrating under vacuum, the crude product was purified by column chromatography 
(Pentane/DCM= 10:1) to afford 39 as yellow oil (43 mg, 0.28 mmol, 78%). 
Rf (Pentane / DCM= 10 / 1): 0.4. 1H NMR (400 MHz, CDCl3) δ 7.85 (s, 1 H, benzeneH), 7.38 
(dd, 1 H, J = 1.3, 8.4 Hz, benzeneH), 7.26 (d, 1 H, J = 8.4 Hz, benzeneH), 7.07 (d, 1 H, J = 
3.1 Hz, pyrroleH), 6.50 (d, 1 H, J = 3.1 Hz, pyrroleH), 3.77 (s, 3 H, NCH3), 3.04 (s, 1 H, 
Alkyne H). 13C NMR (101 MHz, CDCl3) δ 136.5, 129.8, 128.1, 125.4, 113.6, 112.5, 109.2, 
101.2, 85.4, 74.6, 32.8.  IR 1484 (w), 1334 (w), 1245 (w), 886 (w), 805 (w), 728 (w). HRMS 
(ESI) calcd for C11H9N [M+] 156.0808; found 156.0809. 
5-Ethynyl-1-methyl-3-((triisopropylsilyl)ethynyl)-1H-indole (11) 
 
 
Gold(I) chloride (3.7 mg, 0.016 mmol, 0.050 equiv) was added into a solution of 39 (0.050 g, 
0.32 mmol, 1.0 equiv), 1b (0.166 g, 0.387 mmol, 1.2 equiv), sodium bicarbonate (0.032 g, 
0.39 mmol, 1.2 equiv) in Et2O (8 mL). The solvent was removed under vaccum, and the crude 
product was purified by column chromatography (Pentane/EtOAc= 15:1) directly without any 
further work-up. 11 was obtained as yellow oil (68 mg, 0.20 mmol, 63%, 90% based on the 
unconsumed starting material determined from the 1H NMR spectra of crude product) 
Rf (Pentane/EtOAc= 15:1): 0.3. 1H NMR (400 MHz, CDCl3) δ 7.87 (s, 1 H, benzeneH), 7.38 
(dd, 1 H, J = 1.5, 8.5 Hz, benzeneH), 7.29 (s, 1 H, pyrroleH), 7.23 (d, 1 H, J = 8.5 Hz, 
benzeneH), 3.75 (s, 3 H, NCH3), 3.05 (s, 1 H, Alkyne H), 1.17 (s, 21 H, TIPS).  
13C NMR (101 
MHz, CDCl3) δ 135.8, 133.7, 129.2, 126.6, 124.7, 113.7, 109.6, 99.5, 98.0, 92.2, 85.0, 75.3, 
33.1, 18.8, 11.4.  IR 3311 (w), 3296 (w), 2945 (s), 2893 (w), 2865 (s), 2148 (s), 1479 (m), 
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1468 (m), 1374 (m), 1249 (w), 1017 (w), 997 (w), 910 (w), 888 (s), 804 (m), 731 (s).  HRMS 
(ESI) calcd for C22H29NSi
+ [M]+ 336.2142; found 336.2147. 
6-Ethynyl-1-methyl-7-(naphthalen-1-yl)-1H-indole (40) 
 
TBAF (0.18 mL, 0.18 mmol, 1.2 equiv) was added slowly into a solution of 10d (65 mg, 0.15 
mmol, 1.0 equiv) in THF (3 mL) at 0 °C. The reaction was quenched with a sat NH4Cl 
solution (20 mL) after 30 min. The aqueous and organic layers were separated and the 
aqueous layer was extracted with ether (3x10 mL). After drying over MgSO4 and 
concentrating under vacuum, the crude product was purified by column chromatography 
(Pentane/DCM= 10:1) to afford 40 as a yellow oil (35 mg, 0.12 mmol, 84%). 
Rf (Pentane / DCM= 10 / 1): 0.4. 1H NMR (400 MHz, CDCl3) δ 7.97-7.93 (m, 2 H, 
benzeneH), 7.66 (d, 1 H, J = 8.2 Hz, benzeneH), 7.60-7.54 (m, 2 H, benzeneH), 7.49 (m, 1 H, 
benzeneH), 7.42-7.34 (m, 3 H, benzeneH), 6.95 (d, 1 H, J = 3.1 Hz, pyrroleH), 6.56 (d, 1 H, J 
= 3.1 Hz, pyrroleH), 2.85 (s, 3 H, NCH3), 2.65 (s, 1 H, Alkyne H). 
13C NMR (101 MHz, 
CDCl3) δ 135.7, 134.5, 133.4, 133.1, 132.3, 129.8, 128.4, 128.2, 128.1, 127.6, 126.3, 125.9, 
124.9, 124.0, 120.3, 116.1, 101.1, 83.9, 78.6, 35.5 (one carbon signal not resolved). IR 3305 
(w), 1325 (w), 1324 (w), 1315 (w), 907 (s), 815 (w), 806 (w), 779 (w), 728 (s). HRMS (ESI) 
calcd for C21H15N
+ [M]+ 282.1277; found 282.1284.  
1-Methyl-1H-phenanthro[3,4-g]indole (12) 
 
 
PtCl2 (3.3 mg, 0.012 mmol, 0.1 equiv) was added into a solution of 40 (35 mg, 0.12 mmol, 
1.0 equiv) in toluene (4.8 mL). The mixture was kept at 100 oC overnight. The crude product 
was purified by column chromatography (Pentane/DCM= 10:1) directly to afford 12 as a 
yellow oil (26 mg, 0.092 mmol, 74 %). 
Rf (Pentane / DCM= 10 / 1): 0.4. 1H NMR (400 MHz, CDCl3) δ 8.31-8.29 (m, 1 H, 
benzeneH), 7.99-7.97 (m, 2 H, benzeneH), 7.92-7.90 (m, 3 H, benzeneH), 7.76 (d, 1 H, J = 8.3 
Hz, benzeneH), 7.68 (d, 1 H, J = 8.3 Hz, benzeneH), 7.52 (m, 1 H, benzeneH), 7.40 (m, 1 H, 
benzeneH), 7.07 (d, 1 H, J = 3.1 Hz, pyrroleH), 6.81 (d, 1 H, J = 3.1 Hz, pyrroleH), 2.96 (s, 3 
H, NCH3). 
13C NMR (101 MHz, CDCl3) δ 134.5, 131.6, 131.4, 131.0, 131.0, 130.3, 128.3, 
128.0, 127.9, 126.7, 126.2, 125.9, 125.6, 125.2, 124.8, 124.2, 121.2, 120.6, 116.6, 103.3, 37.2. 
IR 3052 (w), 1344 (w), 1265 (m), 840 (w), 819 (w), 790 (w), 773 (w), 734 (s), 705 
(m).HRMS (ESI) calcd for C21H15N
+ [M]+ 282.1277; found 282.1280.  
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6. Spectra for new comprounds 
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